<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78610</article-id><article-id pub-id-type="doi">10.7554/eLife.78610</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Cellular mechanisms underlying central sensitization in a mouse model of chronic muscle pain</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-273997"><name><surname>Lin</surname><given-names>Yu-Ling</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274002"><name><surname>Yang</surname><given-names>Zhu-Sen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273996"><name><surname>Wong</surname><given-names>Wai-Yi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274003"><name><surname>Lin</surname><given-names>Shih-Che</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273999"><name><surname>Wang</surname><given-names>Shuu-Jiun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-274000"><name><surname>Chen</surname><given-names>Shih-Pin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273998"><name><surname>Cheng</surname><given-names>Jen-Kun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2384-7856</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-274001"><name><surname>Lu</surname><given-names>Hui</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-28309"><name><surname>Lien</surname><given-names>Cheng-Chang</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6692-9942</contrib-id><email>cclien@ym.edu.tw</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00se2k293</institution-id><institution>Institute of Neuroscience, National Yang Ming Chiao Tung University</institution></institution-wrap><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00se2k293</institution-id><institution>Brain Research Center, National Yang Ming Chiao Tung University</institution></institution-wrap><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ymy8z76</institution-id><institution>Department of Neurology, Neurological Institute, Taipei Veterans General Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00se2k293</institution-id><institution>Faculty of Medicine, National Yang Ming Chiao Tung University</institution></institution-wrap><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00se2k293</institution-id><institution>Institute of Clinical Medicine, National Yang Ming Chiao Tung University</institution></institution-wrap><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ymy8z76</institution-id><institution>Division of Translational Research, Department of Medical Research, Taipei Veterans General Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t89kj24</institution-id><institution>Department of Medicine, MacKay Medical College</institution></institution-wrap><addr-line><named-content content-type="city">New Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/015b6az38</institution-id><institution>Department of Anesthesiology, MacKay Memorial Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>Department of Pharmacology and Physiology, George Washington University</institution></institution-wrap><addr-line><named-content content-type="city">Washington</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Capogna</surname><given-names>Marco</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01aj84f44</institution-id><institution>University of Aarhus</institution></institution-wrap><country>Denmark</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Westbrook</surname><given-names>Gary L</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/009avj582</institution-id><institution>Oregon Health and Science University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>15</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e78610</elocation-id><history><date date-type="received" iso-8601-date="2022-03-14"><day>14</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-10-22"><day>22</day><month>10</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-03-25"><day>25</day><month>03</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.03.22.485320"/></event></pub-history><permissions><copyright-statement>© 2022, Lin et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lin et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78610-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-78610-figures-v1.pdf"/><abstract><p>Chronic pain disorders are often associated with negative emotions, including anxiety and depression. The central nucleus of the amygdala (CeA) has emerged as an integrative hub for nociceptive and affective components during central pain development. Prior adverse injuries are precipitating factors thought to transform nociceptors into a primed state for chronic pain. However, the cellular basis underlying the primed state and the subsequent development of chronic pain remains unknown. Here, we investigated the cellular and synaptic alterations of the CeA in a mouse model of chronic muscle pain. In these mice, local infusion of pregabalin, a clinically approved drug for fibromyalgia and other chronic pain disorders, into the CeA or chemogenetic inactivation of the somatostatin-expressing CeA (CeA-SST) neurons during the priming phase prevented the chronification of pain. Further, electrophysiological recording revealed that the CeA-SST neurons had increased excitatory synaptic drive and enhanced neuronal excitability in the chronic pain states. Finally, either chemogenetic inactivation of the CeA-SST neurons or pharmacological suppression of the nociceptive afferents from the brainstem to the CeA-SST neurons alleviated chronic pain and anxio-depressive symptoms. These data raise the possibility of targeting treatments to CeA-SST neurons to prevent central pain sensitization.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>chronic muscle pain</kwd><kwd>amygdala</kwd><kwd>central sensitization</kwd><kwd>somatostatin</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004737</institution-id><institution>National Health Research Institutes</institution></institution-wrap></funding-source><award-id>NHRI-EX111-11135NI</award-id><principal-award-recipient><name><surname>Lien</surname><given-names>Cheng-Chang</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id><institution>Ministry of Science and Technology, Taiwan</institution></institution-wrap></funding-source><award-id>MOST 108-2320-B-010-026-MY3</award-id><principal-award-recipient><name><surname>Lien</surname><given-names>Cheng-Chang</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id><institution>Ministry of Science and Technology, Taiwan</institution></institution-wrap></funding-source><award-id>MOST 109-2926-I-010-506</award-id><principal-award-recipient><name><surname>Lien</surname><given-names>Cheng-Chang</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id><institution>Ministry of Science and Technology, Taiwan</institution></institution-wrap></funding-source><award-id>MOST 110-2321-B-010-006</award-id><principal-award-recipient><name><surname>Lien</surname><given-names>Cheng-Chang</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id><institution>Ministry of Science and Technology, Taiwan</institution></institution-wrap></funding-source><award-id>MOST 111-2321-B-A49-005</award-id><principal-award-recipient><name><surname>Lien</surname><given-names>Cheng-Chang</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Maladaptive changes of pro-nociceptive neurons in the central nucleus of the amygdala drive the chronification of muscle pain and comorbid affective behaviors.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Prior adverse events or perceived physical injuries are one of the precipitating factors for chronic pain (<xref ref-type="bibr" rid="bib40">Mills et al., 2019</xref>; <xref ref-type="bibr" rid="bib49">Stevans et al., 2021</xref>). A prior injury is thought to transform nociceptors into a primed state, which lasts variably in different types of chronic pain disorders (<xref ref-type="bibr" rid="bib32">Kandasamy and Price, 2015</xref>; <xref ref-type="bibr" rid="bib45">Reichling and Levine, 2009</xref>; <xref ref-type="bibr" rid="bib50">Sun and Chen, 2016</xref>). Subsequent injuries occurring during the priming phase can result in the chronification of pain (<xref ref-type="bibr" rid="bib50">Sun and Chen, 2016</xref>). Acid-induced muscle pain (MP) in rodents, which is a preclinical model for chronic MP disorders, including fibromyalgia syndrome, requires two episodes of acute MP induction (<xref ref-type="bibr" rid="bib47">Sluka et al., 2001</xref>). Specifically, the second acid injection into the gastrocnemius muscle of animals during a priming phase is warranted for the development of chronic MP (<xref ref-type="bibr" rid="bib12">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Sluka and Clauw, 2016</xref>; <xref ref-type="bibr" rid="bib50">Sun and Chen, 2016</xref>). Chronic pain disorders are associated with psychiatric comorbidities (<xref ref-type="bibr" rid="bib25">Hooten, 2016</xref>; <xref ref-type="bibr" rid="bib52">Velly and Mohit, 2018</xref>). Indeed, patients with fibromyalgia syndrome have chronic widespread pain and other comorbid symptoms, for example, sleep, psychological, and cognitive disturbances (<xref ref-type="bibr" rid="bib16">Clauw, 2014</xref>; <xref ref-type="bibr" rid="bib48">Sluka and Clauw, 2016</xref>).</p><p>Central sensitization is believed to underlie widespread MP and affective symptoms in the fibromyalgia syndrome (<xref ref-type="bibr" rid="bib16">Clauw, 2014</xref>; <xref ref-type="bibr" rid="bib55">Woolf, 2011</xref>). However, the cellular basis underpinning central sensitization in MP disorders is poorly elucidated. Among the anatomically and functionally distinct amygdaloid nuclei (<xref ref-type="bibr" rid="bib19">Duvarci and Pare, 2014</xref>; <xref ref-type="bibr" rid="bib36">LeDoux, 2000</xref>), the central nucleus of the amygdala (CeA) has emerged as an integrative hub for nociceptive and affective components during the development of chronic pain states (<xref ref-type="bibr" rid="bib35">Kuner and Kuner, 2021</xref>; <xref ref-type="bibr" rid="bib42">Neugebauer et al., 2004</xref>; <xref ref-type="bibr" rid="bib51">Thompson and Neugebauer, 2017</xref>). The CeA receives a direct nociceptive projection from the parabrachial nucleus (PBN). Maladaptive changes in synaptic transmission at the PBN to the CeA neuron synapses are thought to underlie persistent pathological pain states (<xref ref-type="bibr" rid="bib30">Ikeda et al., 2007</xref>; <xref ref-type="bibr" rid="bib38">Li and Sheets, 2020</xref>; <xref ref-type="bibr" rid="bib54">Wilson et al., 2019</xref>). The CeA houses distinct gamma aminobutyric acid (GABA)-ergic neuronal populations; the two major groups include the somatostatin-expressing (SST) and protein kinase C delta-expressing (PKCδ) neurons (<xref ref-type="bibr" rid="bib3">Babaev et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Haubensak et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Hou et al., 2016</xref>). These two types of neurons form a reciprocal inhibitory circuit (<xref ref-type="bibr" rid="bib3">Babaev et al., 2018</xref>; <xref ref-type="bibr" rid="bib15">Ciocchi et al., 2010</xref>; <xref ref-type="bibr" rid="bib23">Haubensak et al., 2010</xref>). It is believed that PKCδ neurons are pro-nociceptive, whereas SST neurons are antinociceptive under physiological conditions (<xref ref-type="bibr" rid="bib54">Wilson et al., 2019</xref>). However, the role of these two types of neurons in the regulation of nociception is inconsistent in different chronic pain models (<xref ref-type="bibr" rid="bib13">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="bib54">Wilson et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Zhou et al., 2019</xref>).</p><p>Here, we aimed to investigate the cellular basis underlying MP using the acid-induced MP model. By combining electrophysiology, chemogenetics, and in vivo calcium imaging, we attempted to demonstrate that CeA-SST neurons, which are believed to be antinociceptive neurons, become hyperexcitable following MP development. Consistent with this finding, selective chemogenetic inactivation of CeA-SST neurons or suppression of synaptic transmission of the PBN to the CeA-SST neurons alleviated MP and negative emotions.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Intra-CeA application of pregabalin alleviated pain in an MP mouse model</title><p>Acid-induced MP in rats or mice is considered a preclinical model of fibromyalgia (<xref ref-type="bibr" rid="bib14">Cheng et al., 2011</xref>; <xref ref-type="bibr" rid="bib41">Min et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Sluka et al., 2001</xref>). In this study, we induced MP in mice using a well-established protocol for acid-induced MP. Mice with acidic (pH 4.0) saline injected into the gastrocnemius muscle unilaterally on day 0 (baseline [BL]) and day 3 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) are referred to as the MP mice. Following the first acidic saline injection, the MP mice showed a transient decrease in the paw withdrawal (PW) threshold in both the ipsilateral (‘ipsi’) and contralateral (‘contra’) hind limbs in response to the von Frey filament stimulation (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The acute pain mostly recovered by day 3 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). A second injection, however, caused a sustained decrease in the PW threshold that lasted for at least 14 days (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). In contrast to the MP mice, the neutral (pH 7.2) saline-injected mice, referred to as the control (Ctrl) mice, showed no significant changes in the PW response to the von Frey filament stimulation (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Collectively, only the MP mice exhibited an increase in the PW response to a wide range of von Frey filament stimulations bilaterally (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The mechanical hypersensitivity induced in the MP mice lasted for at least 2 weeks (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Local application of pregabalin (PGB) in the central nucleus of the amygdala (CeA) alleviated pain in a muscle pain (MP) mouse model.</title><p>(<bold>A</bold>) Schematic of MP induction protocol and experimental timeline. Mice were injected with either neutral (pH 7.2, Ctrl mice) or acidic (pH 4.0, MP mice) saline into the gastrocnemius muscle unilaterally on days 0 and 3. (<bold>B</bold>) Plot of the paw withdrawal (PW) threshold to the mechanical stimuli over time (Ctrl, n=26; MP, n=28; two-way analysis of variance (ANOVA) with Tukey’s post hoc test, F(8,936) = 30.97, ****p&lt;0.0001 relative to baseline [BL]). (<bold>C</bold>) The bilateral PW responses to different filaments on day 14 in the Ctrl and MP mice (Ctrl, n=8; MP, n=9; two-way ANOVA with Tukey’s post hoc test, F(3,180) = 121.1, <sup>#</sup>p&lt;0.05, ****<sup>,####</sup>p&lt;0.0001; * indicates the comparison between ipsilateral hindpaws; <sup>#</sup> indicates the comparison between contralateral hindpaws). (<bold>D</bold>) Representative image of the PGB infusion site (labeled with a red fluorescent dye, sulforhodamine 101) and experimental schematic. (<bold>E</bold>) Effects of PGB treatment on the PW threshold in the Ctrl and MP mice (Ctrl, n=13; MP, n=12; two-way ANOVA with Tukey’s post hoc test, F(12,598) = 38.2, ****<sup>,####</sup>p&lt;0.0001 relative to day 15; * indicates the comparison between the ipsilateral hindpaws; <sup>#</sup> indicates the comparison between the contralateral hindpaws. The blue area indicates the period of PGB treatment). (<bold>F</bold>) Top, experimental timeline. Right after the second injection of the acidic saline, one of the mouse groups was infused with PGB, and the other with artificial cerebrospinal fluid (ACSF). Bottom, effects of PGB treatment on the PW threshold in the ACSF and PGB groups (ACSF, n=8; PGB, n=9; two-way ANOVA with Tukey’s post hoc test, F(3,270) = 48.7, ***p&lt;0.001, ****<sup>,####</sup>p&lt;0.0001; * indicates the comparison between the ipsilateral hindpaws; <sup>#</sup> indicates the comparison between the contralateral hindpaws. The blue area indicates the period of PGB treatment).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Comorbid affective symptoms in a muscle pain (MP) mouse model.</title><p>(<bold>A</bold>) Top, representative travel trajectories of each group during the elevated plus maze (EPM) test. Bottom, summary plots of open-arm time (Ctrl, 22.3 ± 1.3%, n=15; MP, 14.7 ± 1.3%, n=15; Mann–Whitney test, U=33, ***p=0.001) and total distance (Ctrl, 21.9±0.6 m, n=15; MP, 21.9±1.6 m, n=15; Mann–Whitney test, U=95, n.s., non-significant, p=0.48). (<bold>B</bold>) Top, representative travel trajectories of each group during the light/dark (L/D) box test. Bottom, summary plots of light-zone time (Ctrl, 277.4±16.1 s, n=19; MP, 214.5±11.9 s, n=22; Mann–Whitney test, U=79, ***p=0.0004), number of transitions (Ctrl, 35.5±2.4, n=19; MP, 26.6±1.5, n=22; Mann–Whitney test, U=104.5, **p=0.005) and total distance (Ctrl, 26.1±1.6 m, n=19; MP, 25.3±1.0 m, n=22; Mann–Whitney test, U=169, n.s., non-significant, p=0.303). (<bold>C</bold>) Top, representative results of the marble burying test. Bottom, summary plot of the number of buried marbles (Ctrl, 7.9±0.9, n=8; MP, 13.7±1.6, n=9; Mann–Whitney test, U=12, *p=0.018). (<bold>D</bold>) Top, schematic of the forced swim test (FST). Bottom, summary plot of immobility time (Ctrl, 48.6 ± 2.9%, n=14; MP, 64.7 ± 2.1%, n=14; Mann–Whitney test, U=23, ***p=0.0003). (<bold>E</bold>) Top, representative trajectories of each group during the three-chamber sociability test. Bottom, summary plots of relative time in the social zone (Ctrl, 57.3 ± 3.2%, n=11; MP, 46.3 ± 2.2%, n=13; Mann–Whitney test, U=28, *p=0.011) and total distance (Ctrl, 28.2±1.4 m, n=11; MP, 27.4±1.8 m, n=13; Mann–Whitney test, U=66, n.s., non-significant, p=0.766).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Expression of α2δ in the parabrachial nucleus (PBN).</title><p>Serial coronal section of α2δ1 and α2δ2 expression in the PBN obtained from the Allen Mouse Brain Connectivity Atlas which was published by Allen Brain Institute (α2δ1: <ext-link ext-link-type="uri" xlink:href="http://mouse.brain-map.org/experiment/show?id=72119649;">http://mouse.brain-map.org/experiment/show?id=72119649;</ext-link> α2δ2:<ext-link ext-link-type="uri" xlink:href="http://mouse.brain-map.org/experiment/show?id=72119650">http://mouse.brain-map.org/experiment/show?id=72119650</ext-link>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig1-figsupp2-v1.tif"/></fig></fig-group><p>In addition to mechanical allodynia, the mice with MP showed various affective symptoms (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The elevated plus maze (EPM) and light/dark (L/D) box are common approach-avoidance conflict tests based on the general aversion of mice to bright and open environments (<xref ref-type="bibr" rid="bib7">Calhoon and Tye, 2015</xref>; <xref ref-type="bibr" rid="bib53">Walf and Frye, 2007</xref>). Anxious mice prefer to stay in the closed arms and dark compartment. Compared to the Ctrl mice, the MP mice spent less time in the open arms (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) and made fewer transitions between the light and dark zones in the L/D box test (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Neither of these behavioral phenotypes was due to reduced locomotion because the total travel distances of the MP and Ctrl mice were not significantly different (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>). We also tested mice in the marble burying test where anxious animals directed their energies toward minimizing threatening stimuli and tended to bury more marbles. Compared to the Ctrl mice, the MP mice buried more marbles in the marble burying test (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>).</p><p>Anxiety disorders are often associated with depression-like behavior and social avoidance (<xref ref-type="bibr" rid="bib2">Allsop et al., 2014</xref>). The forced swim test (FST) is commonly used for testing depression-like behavior in mice. Compared to the Ctrl mice, the MP mice spent more time in the floating state, suggesting enhanced depression-like behavior (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Finally, we tested the sociability of the mice by measuring the time spent in a social chamber containing a novel mouse (<xref ref-type="bibr" rid="bib56">Yang et al., 2011</xref>). Accordingly, the MP mice spent less time in the social chamber than the Ctrl mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). The total travel distance of the MP mice was not significantly different from that of the Ctrl mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). Taken together, these results suggest that the MP mice exhibited mechanical allodynia and hyperalgesia as well as a variety of behavioral traits commonly associated with anxiety and depression. Thus, the acid-induced MP model satisfies the face validity of chronic MP (<xref ref-type="bibr" rid="bib7">Calhoon and Tye, 2015</xref>).</p><p>Therefore, we tested the predictive validity of this model. Pregabalin (PGB) is a Food and Drug Administration-approved drug for the treatment of chronic pain disorders and affective comorbidities. PGB is a selective ligand for the α2δ subunit of voltage-gated calcium channels (VGCCs; <xref ref-type="bibr" rid="bib24">Häuser et al., 2009</xref>). However, the exact action site of PGB on both the sensory and affective dimensions is unknown. The CeA receives a direct nociceptive projection from the PBN, which is enriched with the calcium channel α2δ subunit (<xref ref-type="bibr" rid="bib17">Cole et al., 2005</xref>; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). To test whether PGB acted on the PBN-CeA pathway, we locally infused PGB into the CeA of the Ctrl and MP mice bilaterally through a cannula (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Compared to the Ctrl mice, cannula infusion of PGB (1 mM, 0.15 μL/site), instead of a vehicle (artificial cerebrospinal fluid [ACSF]), into the CeA of the MP mice on days 16 and 19 increased the PW threshold (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). This result supports the predictive validity of this model.</p><p>In this model, the first acidic saline injection initiated a priming phase, which reportedly lasts for 5–8 days (<xref ref-type="bibr" rid="bib12">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="bib50">Sun and Chen, 2016</xref>). Therefore, we determined whether earlier administration of PGB could prevent chronic pain development. Thus, we infused ACSF or PGB bilaterally through a cannula on day 3 into the CeA of the MP mice right after the second acidic saline injection (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). The group infused with ACSF was able to develop chronic pain effectively. In contrast, the pain response of the group infused with PGB became weakened (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). This result demonstrated that local infusion of PGB into the CeA during hyperalgesic priming was sufficient to prevent the development of chronic pain.</p></sec><sec id="s2-2"><title>Local infusion of PGB into the CeA alleviated negative emotions</title><p>To test whether local PGB administration in the CeA also alleviated negative emotions in the MP mice, we infused PGB into the CeA of the Ctrl and MP mice bilaterally through a cannula (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Cannula infusion of PGB (1 mM, 0.15 μL/site), instead of a vehicle (ACSF), into the CeA increased the open-arm time (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) in the EPM test and decreased the number of buried marbles in the marble burying test (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) in the MP mice compared to the Ctrl mice. In addition, we tested depression-like behavior and sociability of the mice using the FST and three-chambered social test. Local infusion of PGB into the CeA decreased the immobility time in the FST (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) and increased the social-zone time in the three-chambered social test (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) in the MP mice compared the Ctrl mice. Notably, PGB at the dosage used in this study had no effect on locomotion (<xref ref-type="fig" rid="fig2">Figure 2B and E</xref>) and had little effect on the affective behaviors in the Ctrl mice (<xref ref-type="fig" rid="fig2">Figure 2B–E</xref>). These results indicated that local infusion of PGB in the CeA in chronic pain conditions alleviated negative emotions.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Local infusion of pregabalin (PGB) in the central nucleus of the amygdala (CeA) alleviated negative emotions.</title><p>(<bold>A</bold>) Experimental timeline. (<bold>B</bold>) Top, representative travel trajectories of each Ctrl and muscle pain (MP) group during the elevated plus maze (EPM) test. Bottom, summary of the effects of PGB treatment on open-arm time (Ctrl: artificial cerebrospinal fluid [ACSF], 29.6 ± 3.8%, n=6; PGB, 20.0 ± 2.7%, n=5; Mann–Whitney test, U=4, n.s., non-significant, p=0.052. MP: ACSF, 15.1 ± 3.0%, n=7; PGB, 38.4 ± 5.1%, n=7; Mann–Whitney test, U=2, **p=0.002) and total distance (Ctrl: ACSF, 24.1±2.9 m, n=6; PGB, 22.9±2.1 m, n=5; Mann–Whitney test, U=14, n.s., non-significant, p=0.875. MP: ACSF, 21.4±1.0 m, n=7; PGB, 22.7±2.3 m, n=7; Mann–Whitney test, U=18, n.s., non-significant, p=0.446). (<bold>C</bold>) Summary of the effects of PGB treatment on the number of buried marbles (Ctrl: ACSF, 8.9±1.5, n=8; PGB, 8.8±1.0, n=8; Wilcoxon matched-pairs signed rank test, n.s., non-significant, p=0.938. MP: ACSF, 15.0±0.6, n=8; PGB, 8.6±1.1, n=8; Wilcoxon matched-pairs signed rank test, **p=0.008). (<bold>D</bold>) Summary of relative time of immobility in the forced swim test (FST) (Ctrl: ACSF, 44.2 ± 3.3%, n=9; PGB, 46.1 ± 3.0%, n=9; Wilcoxon matched-pairs signed rank test, n.s., non-significant, p=0.734. MP: ACSF, 57.4 ± 2.4%, n=8; PGB, 46.0 ± 2.8%, n=8; Wilcoxon matched-pairs signed rank test, *p=0.023). (<bold>E</bold>) Top, representative travel trajectories of each Ctrl and MP group during the three-chamber sociability test. Bottom, summary of the effects of PGB treatment on social-zone time (Ctrl: ACSF, 44.6 ± 4.8%, n=6; PGB, 37.8 ± 3.8%, n=7; Mann–Whitney test, U=10, n.s., non-significant, p=0.138. MP: ACSF, 34.2 ± 2.9%, n=6; PGB, 48.6 ± 5.0%, n=6; Mann–Whitney test, U=5, *p=0.041) and total distance (Ctrl: ACSF, 42.3±2.3 m, n=6; PGB, 35.2±2.7 m, n=7; Mann–Whitney test, U=9, n.s., non-significant, p=0.101. MP: ACSF, 39.5±2.8 m, n=6; PGB, 38.0±3.6 m, n=6; Mann–Whitney test, U=15, n.s., non-significant, p=0.675). (<bold>F</bold>) Experimental timeline. Right after the second injection of the acidic saline, one of the mouse groups was infused with PGB, and the other with ACSF. The behavior assessments were performed on day 14. (<bold>G</bold>) Top, representative travel trajectories of each ACSF and PGB group during the EPM test. Bottom, summary of the effects of PGB treatment on the open-arm time (ACSF, 22.1 ± 3.1%, n=8; PGB, 40.5 ± 4.8%, n=9; Mann–Whitney test, U=10, *p=0.011) and total distance (ACSF, 20.4±2.3, n=8; PGB, 25.2±3.1, n=9; Mann–Whitney test, U=25, n.s., non-significant, p=0.315). (<bold>H</bold>) Summary of the effects of PGB treatment on the number of buried marbles (ACSF, 17.6±1.2, n=5; PGB, 9.0±0.9, n=6; Mann–Whitney test, U=0, **p=0.004). (<bold>I</bold>) Summary of the effects of PGB treatment on the immobility time (ACSF, 54.8±0.9, n=5; PGB, 41.0±2.4, n=6; Mann–Whitney test, U=0, **p=0.004). (<bold>J</bold>) Top, representative travel trajectories of each ACSF and PGB group during the three-chamber sociability test. Bottom, summary of the effects of PGB treatment on social-zone time (ACSF, 33.2±2.6, n=8; PGB, 42.1±1.9, n=9; Mann–Whitney test, U=11, *p=0.015) and total distance (ACSF, 39.8±1.8, n=8; PGB, 40.7±2.8, n=9; Mann–Whitney test, U=33, n.s., non-significant, p=0.791).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Correlation of the effect of pregabalin (PGB) on the mechano-sensitivity and emotional behavior.</title><p>(<bold>A</bold>) Plot of the change of immobility time against the change of paw withdrawal (PW) threshold (n=8). (<bold>B</bold>) Plot of the change of number of buried marbles against the change of PW threshold (n=8).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Considering that the PGB treatment during the priming phase is sufficient for preventing chronic pain development, we also tested whether PGB delivery during the priming phase can prevent comorbid affective symptoms. Thus, we infused ACSF or PGB into the CeA of the MP mice bilaterally through a cannula right after the second acidic saline injection (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). The same behavior assessments were performed in this experiment on day 14 (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Cannula infusion of PGB in the primed state increased the exploration time in the open arms (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), decreased the number of marbles buried (<xref ref-type="fig" rid="fig2">Figure 2H</xref>), decreased the immobility time (<xref ref-type="fig" rid="fig2">Figure 2I</xref>), and increased the social-zone time (<xref ref-type="fig" rid="fig2">Figure 2J</xref>) in the MP mice compared to the ACSF group. Taken together, the infusion of PGB immediately after the second acidic saline injection interfered with the hyperalgesic priming, thereby preventing the development of chronic pain-related comorbid affective emotions in the MP mice.</p></sec><sec id="s2-3"><title>MP was associated with enhanced synaptic transmission and neuronal excitability in the CeA-SST neurons</title><p>To characterize maladaptive changes in the amygdala circuits in chronic MP states, we recorded the excitatory synaptic transmission to the CeA-SST and CeA-PKCδ neurons using whole-cell patch-clamp recording in brain slices from the Ctrl and MP mice (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Using the Cre-loxP recombination approach, we identified the CeA-SST and CeA-PKCδ neurons in the SST-Cre;Ai14 and PKCδ-Cre;Ai14 mice, respectively (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Compared to the Ctrl mice, MP mice had an increase in the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) in the CeA-SST neurons (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The amplitude of sEPSCs in the MP mice, however, was not significantly different from that in the Ctrl mice (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In contrast to the CeA-SST neurons, recordings from the CeA-PKCδ neurons of the MP mice showed a significant decrease in the sEPSC frequency; however, no change was observed in the sEPSC amplitude compared to the Ctrl mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Similar results were observed in miniature excitatory postsynaptic currents (mEPSCs; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>), suggesting that excitatory synaptic transmission onto the CeA-SST neurons was strengthened, while that onto the CeA-PKCδ neurons was weakened.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Altered excitatory transmission to the central nucleus of the amygdala (CeA) neurons and changed CeA neuron excitability in muscle pain (MP) mice.</title><p>(<bold>A</bold>) Experimental schematic and timeline. (<bold>B</bold>) Overlay of epifluorescence and IR-DIC images showing somatostatin-expressing (SST) and protein kinase C delta-expressing (PKCδ) neurons in the CeA. Sections from the SST-Cre;Ai14 and PKCδ-Cre;Ai14 mouse brains. (<bold>C</bold>) Top, representative spontaneous excitatory postsynaptic current (sEPSC) traces recorded from the CeA-SST neurons of the Ctrl and MP mice. Bottom, cumulative probability of inter-event interval (Ctrl, n=9; MP, n=20; Kolmogorov–Smirnov test, **p=0.0014. Inset, summary of sEPSC frequency, Ctrl, 2.2±0.5 Hz, n=9; MP, 4.3±0.6 Hz, n=20; Mann–Whitney test, U=33, **p=0.006) and amplitude (Ctrl, n=9; MP, n=20; Kolmogorov–Smirnov test, n.s., non-significant, p=0.998. Inset, summary of sEPSC amplitude, Ctrl, 14.9±1.8 pA, n=9; MP, 16.9±1.1 pA, n=20; Mann–Whitney test, U=72, n.s., non-significant, p=0.404). (<bold>D</bold>) Top, representative sEPSC traces recorded from the CeA-PKCδ neurons of the Ctrl and MP mice. Bottom, cumulative probability of inter-event interval (Ctrl, n=9; MP, n=20; Kolmogorov–Smirnov test, ****p&lt;0.0001. Inset, summary of sEPSC frequency, Ctrl, 5.1±0.9 Hz, n=9; MP, 2.3±0.3 Hz, n=20; Mann–Whitney test, U=36, **p=0.0097) and amplitude (Ctrl, n=9; MP, n=20; Kolmogorov–Smirnov test, n.s., non-significant, p=0.996. Inset, summary of sEPSC amplitude, Ctrl, 16.5±0.6 pA, n=9; MP, 14.7±1.0 pA, n=20, Mann–Whitney test, U=60, n.s., non-significant, p=0.167). (<bold>E</bold>) Representative responses of the CeA-SST and CeA-PKCδ neurons in the Ctrl and MP mice to depolarizing current injections. (<bold>F</bold>) Plot of number of spikes in the CeA-SST neurons against injected current (Ctrl, n=15; MP, n=28; two-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test, F(1,202) = 10.49, **p=0.0014). (<bold>G</bold>) Plot of number of spikes in CeA-PKCδ neurons against injected current (Ctrl, n=11; MP, n=20; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,143) = 12.77, ***p=0.0005). (<bold>H</bold>) Summary of rheobase of CeA-SST neurons (Ctrl, 55.7±6.1 pA, n=15; MP, 38.7±4.1 pA, n=28; Mann–Whitney test, U=117, *p=0.017) and CeA-PKCδ neurons (Ctrl, 32±4.7 pA, n=10; MP, 49.6±5.0 pA, n=17; Mann–Whitney test, U=42.5, *p=0.032).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Comparison of miniature excitatory postsynaptic current (mEPSC), resting potential, and input resistance of the central nucleus of the amygdala (CeA) neurons in the Ctrl and muscle pain (MP) mice.</title><p>(<bold>A</bold>) Top, representative traces of mEPSCs recorded from the somatostatin-expressing CeA (CeA-SST) neurons of the Ctrl and MP mice. Bottom, cumulative probability of inter-event interval (Ctrl, n=6; MP, n=17; Kolmogorov–Smirnov test, ****p&lt;0.0001. Inset, summary of mEPSC frequency, Ctrl, 1.4±0.5 Hz, n=6; MP, 2.5±0.3 Hz, n=17, Mann–Whitney test, U=20, *p=0.029) and amplitude (Ctrl, n=6; MP, n=17; Kolmogorov–Smirnov test, n.s., non-significant, p=0.518. Inset, summary of mEPSC amplitude, Ctrl, 11.8±1.8 pA, n=6; MP, 13.1±0.5 pA, n=17, Mann–Whitney test, U=33, n.s., non-significant, p=0.215). (<bold>B</bold>) Top, representative traces of mEPSCs recorded from the CeA-PKCδ neurons of the Ctrl and MP mice. Bottom, cumulative probability of inter-event interval (Ctrl, n=7; MP, n=12; Kolmogorov–Smirnov test, ***p=0.0002. Inset, summary of mEPSC frequency, Ctrl, 4.8±0.8 Hz, n=7; MP, 2.6±0.4 Hz, n=12, Mann–Whitney test, U=17, *p=0.036) and amplitude (Ctrl, n=7; MP, n=12; Kolmogorov–Smirnov test, n.s., non-significant, p=0.993. Inset, summary of mEPSC amplitude, Ctrl, 14.0±0.9 pA, n=7; MP, 14.4±0.8 pA, n=12, Mann–Whitney test, U=34, n.s., non-significant, p=0.514). (<bold>C</bold>) Summary of resting potential of the CeA-SST neurons (Ctrl, –55.3±3.1 mV, n=15; MP, –53.0±2.5 mV, n=28; Mann–Whitney test, U=181, n.s., non-significant, p=0.468). (<bold>D</bold>) Summary of input resistance of the CeA-SST neurons (Ctrl, 0.42±0.04 GΩ, n=10; MP, 0.53±0.05 GΩ, n=25; Mann–Whitney test, U=97, n.s., non-significant, p=0.312). (<bold>E</bold>) Summary of resting potential of the CeA-PKCδ neurons (Ctrl, –64.9±4.3 mV, n=11; MP, –63.8±3.1 mV, n=23; Mann–Whitney test, U=120, n.s., non-significant, p=0.821). (<bold>F</bold>) Summary of input resistance of the CeA-PKCδ neurons (Ctrl, 0.52±0.05 GΩ, n=11; MP, 0.41±0.03 GΩ, n=19; Mann–Whitney test, U=60, n.s., non-significant, p=0.057).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>The total number of SST(+)pERK(+) cells in the central nucleus of the amygdala (CeA) was increased in muscle pain (MP) mice.</title><p>(<bold>A</bold>) Representative images of serial coronal sections. Cells positive are shown for SST-tdTomato (red) and pERK (green). Colocalization of pERK and CeA-SST neurons are indicated with yellow color. High-magnification images are shown on the bottom. (<bold>B</bold>) Left, the total number of pERK(+) cells along the anterior-posterior (AP) axis of the CeA (Ctrl, n=5; MP, n=5; two-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test, F(1,64) = 29.66; ****p&lt;0.0001). Right, summary of total number of pERK(+) cells per mouse (Ctrl, 197.8±16.5, n=5; MP, 321.0±30.6, n=5; Mann–Whitney test, U=1, *p=0.016). (<bold>C</bold>) Left, the number of SST(+)pERK(+) cells along the AP axis (Ctrl, n=5; MP, n=5; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,64) = 34.12, ****p&lt;0.0001, <sup>#</sup>p&lt;0.05; <sup>#</sup> indicates the comparison between the Ctrl and MP groups at each AP position). Right, summary of total number of SST(+)pERK(+) cells per mouse (Ctrl, 8.2±1.0, n=5; MP, 22.0±3.7, n=5; Mann–Whitney test, U=1, *p=0.016). (<bold>D</bold>) Left, the total number of SST(-)pERK(+) cells along the AP axis (Ctrl, n=5; MP, n=5; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,64) = 24.4; ****p&lt;0.0001). Right, summary of total number of SST(-)pERK(+) cells per mouse (Ctrl, 189.6±17.0, n=5; MP, 298.8±30.9, n=5; Mann–Whitney test, U=3, p=0.06).</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig3-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Histogram of the decay time.</title><p>(<bold>A</bold>) Histogram of the decay time recorded from the somatostatin-expressing central nucleus of the amygdala (CeA-SST) neurons of the Ctrl (gray) and muscle pain (MP) (orange) mice. (<bold>B</bold>) Histogram of the decay time recorded from the CeA-protein kinase C delta-expressing (PKCδ) neurons of the Ctrl (gray) and MP (orange) mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig3-figsupp3-v1.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Altered synaptic transmission and excitability of different firing phenotypes of the somatostatin-expressing central nucleus of the amygdala (CeA-SST) and CeA-protein kinase C delta-expressing (PKCδ) neurons in the muscle pain (MP) mice.</title><p>(<bold>A</bold>) Top, the percentage of CeA-SST-ES and CeA-SST-LS neurons in the Ctrl and MP mice quantified after spontaneous excitatory postsynaptic current (sEPSC) recording. Middle, summary of sEPSC frequency (Ctrl, 1.3±0.1 Hz, n=4; MP, 3.5±0.6 Hz, n=9; Mann–Whitney test, U=1, **p=0.006) and amplitude (Ctrl, 14.6±3.0 pA, n=4; MP, 16.9±1.8 pA, n=9; Mann–Whitney test, U=14, p=0.548) of CeA-SST-ES neurons. Bottom, summary of sEPSC frequency (Ctrl, 2.8±0.8 Hz, n=5; MP, 4.9±1.0 Hz, n=11; Mann–Whitney test, U=14, p=0.138) and amplitude (Ctrl, 15.1±2.6 pA, n=5; MP, 16.9±1.5 pA, n=11; Mann–Whitney test, U=23, p=0.617) of CeA-SST-LS neurons. (<bold>B</bold>) Top, the percentage of the CeA-PKCδ-ES and CeA-PKCδ-LS neurons in the Ctrl and MP mice quantified after sEPSC recording. Middle, summary of sEPSC frequency (Ctrl, 4.5±2.2 Hz, n=3; MP, 1.7±0.4 Hz, n=7; Mann–Whitney test, U=5, p=0.267) and amplitude (Ctrl, 17.1±1.6 pA, n=3; MP, 13.9±1.6 pA, n=7; Mann–Whitney test, U=5, p=0.267) of CeA-PKCδ-ES neurons. Bottom, summary of sEPSC frequency (Ctrl, 5.3±1.0 Hz, n=6; MP, 2.6±0.3 Hz, n=13; Mann–Whitney test, U=13, *p=0.022) and amplitude (Ctrl, 16.3±0.6 pA, n=6; MP, 15.2±1.3 pA, n=13; Mann–Whitney test, U=30, p=0.47) of the CeA-PKCδ-LS neurons. (<bold>C</bold>) Top, the percentage of the CeA-SST-ES and CeA-SST-LS neurons in the Ctrl and MP mice. Middle left, plot of number of spikes in the CeA-SST-ES neurons against injected current (Ctrl, n=6; MP, n=12; two-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test, F(1,78) = 10.84, **p=0.0015). Middle right, summary of rheobase of the CeA-SST-ES neurons (Ctrl, 59.7±9.5 pA, n=6; MP, 34.2±6.0 pA, n=12; Mann–Whitney test, U=11.5, *p=0.02). Bottom left, plot of number of spikes in CeA-SST-LS neurons against injected current (Ctrl, n=9; MP, n=16; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,114) = 1.618, p=0.206). Bottom right, summary of rheobase of CeA-SST-LS neurons (Ctrl, 53.0±8.4 pA, n=9; MP, 42.1±5.6 pA, n=16; Mann–Whitney test, U=52.5, p=0.282). (<bold>D</bold>) Top, the percentage of CeA-PKCδ-ES and CeA-PKCδ-LS neurons in the Ctrl and MP mice. Middle left, plot of number of spikes in CeA-PKCδ-ES neurons against injected current (Ctrl, n=4; MP, n=7; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,45) = 16.4, ***p=0.0002). Middle right, summary of rheobase of CeA-PKCδ-ES neurons (Ctrl, 33.8±3.1 pA, n=4; MP, 63.0±13.0 pA, n=5; Mann–Whitney test, U=3, p=0.127). Bottom left, plot of number of spikes in CeA-PKCδ-LS neurons against injected current (Ctrl, n=7; MP, n=13; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,88) = 2.84, p=0.096). Bottom right, summary of rheobase of CeA-PKCδ-LS neurons (Ctrl, 30.8±7.9 pA, n=6; MP, 44.1±4.0 pA, n=12; Mann–Whitney test, U=20.5, p=0.157).</p><p><supplementary-material id="fig3s4sdata1"><label>Figure 3—figure supplement 4—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig3-figsupp4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig3-figsupp4-v1.tif"/></fig></fig-group><p>Next, we investigated whether the intrinsic excitability of the CeA-SST and CeA-PKCδ neurons was altered in the MP mice (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). To determine the changes in intrinsic properties, the CeA neurons were recorded in the presence of synaptic blockers, which blocked glutamatergic and GABAergic transmission (see Materials and methods). Compared to the Ctrl mice, resting membrane potentials and input resistance of the CeA-SST neurons and CeA-PKCδ neurons in the MP mice were not significantly altered (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C-F</xref>). However, the CeA-SST neurons in the MP mice generated more spikes in response to prolonged current injections (<xref ref-type="fig" rid="fig3">Figure 3E</xref> left, <xref ref-type="fig" rid="fig3">Figure 3F</xref>). Conversely, the CeA-PKCδ neurons in the MP mice generated fewer spikes (<xref ref-type="fig" rid="fig3">Figure 3E</xref> right, <xref ref-type="fig" rid="fig3">Figure 3G</xref>). Consistent with these results, the CeA-SST neurons exhibited a lower rheobase (<xref ref-type="fig" rid="fig3">Figure 3H</xref>), while the CeA-PKCδ neurons exhibited a higher rheobase in the MP mice compared to the Ctrl mice (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). These results indicated that cell-intrinsic mechanisms that induce enhancement of excitability in the MP mice are CeA-SST neuron-specific. Consistent with these findings, we observed that the number of phosphorylated extracellular signal-regulated kinase (pERK)-positive CeA cells was increased in the MP mice (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A, B</xref>). Moreover, increased pERK-positive cells were mostly CeA-SST cells (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A, C, D</xref>).</p></sec><sec id="s2-4"><title>Inhibition of the CeA-SST neurons alleviated the pain and affective symptoms</title><p>The increased CeA-SST excitability was associated with chronic pain phenotypes in the MP mice. We sought to determine the causal role of the CeA-SST neurons in the MP development. Therefore, we tested whether suppression of neuronal excitability of the CeA-SST neurons during the initial muscle injuries was sufficient to interfere with the development of chronic pain states. A Cre-dependent adeno-associated virus serotype 5 (AAV5) encoding an inhibitory designer receptor (hM4Di) was injected bilaterally into the CeA of SST-Cre mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Most (~80%) hM4Di-expressing cells, as identified by the mCherry expression, were immunoreactive for SST (<xref ref-type="fig" rid="fig4">Figure 4B</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Whole-cell current-clamp recordings from acute amygdala slices prepared from the mice expressing the hM4Di in the CeA demonstrated that bath application of clozapine-N-oxide (CNO; 5 µM) inhibited spontaneous firing in the hM4Di-expressing SST neurons (<xref ref-type="fig" rid="fig4">Figure 4C<sub>1</sub></xref>). In contrast, CNO had no effect on the firing of the SST neurons, which only expressed mCherry (<xref ref-type="fig" rid="fig4">Figure 4C<sub>2</sub></xref>). To test the essential role of CeA-SST neuronal activity in MP induction, CNO (5 mg/kg body weight) was intraperitoneally (i.p.) injected into the mice immediately after the second acidic saline injection. Silencing the CeA-SST neurons during the primed state prevented the development of MP in the hM4Di-expressing mice compared to the mCherry-expressing mice (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). This result suggests that activation of the CeA-SST neurons following peripheral injury was necessary for pain chronification.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Inactivating the somatostatin-expressing central nucleus of the amygdala (CeA-SST) neurons alleviated pain and affective symptoms.</title><p>(<bold>A</bold>) Viral constructs and experimental schematic. (<bold>B</bold>) Left, representative image of the CeA-SST neurons (green) recognized by an antibody. Middle, representative image of expression of hM4Di-mCherry (red) virus. Right, overlapping image of hM4Di-mCherry and SST antibody signals. (<bold>C<sub>1</sub></bold>) Left, overlay of epifluorescence and IR-DIC images showing mCherry(+) neurons in the CeA. Right, membrane firing frequency changes of an hM4Di-expressing CeA-SST neuron before and after bath application of clozapine-N-oxide (CNO). (<bold>C<sub>2</sub></bold>) Top, representative of raster plots of hM4Di(+) and hM4Di(-) neurons. Blue bar indicates 5 µM CNO application for 2 min. Bottom, normalized firing frequency in both hM4Di(+) and hM4Di(-) neurons (hM4Di(-), n=10; hM4Di(+), n=10; two-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test, F(1,376) = 231.1, ****p&lt;0.0001). (<bold>D</bold>) Effects of the CNO treatment on day 3 on the paw withdrawal (PW) threshold (mCherry, n=5; hM4Di, n=9; two-way ANOVA with Tukey’s post hoc test, F(3,216) = 46.82, ****<sup>,####</sup>p&lt;0.0001; * indicates the comparison between the ipsilateral hindpaw; <sup>#</sup> indicates the comparison between the contralateral hindpaws. The blue area indicates the period of CNO treatment). (<bold>E</bold>) Effects of the CNO treatment on the PW threshold in the muscle pain (MP) mice (mCherry, n=10; hM4Di, n=9; two-way ANOVA with Tukey’s post hoc test, F(9,340) = 124.1, ****p&lt;0.0001 relative to day 14. The blue area indicates the period of CNO treatment). (<bold>F</bold>) Left, representative trajectories of each MP group during the elevated plus maze (EPM) test. Right, summary of the effects of CNO treatment on the open-arm time (mCherry, 16.2 ± 2.5%, n=7; hM4Di, 25.5 ± 2.2%, n=14; Mann–Whitney test, U=19, *p=0.025) and total distance (mCherry, 18.7±1.3 m, n=7; hM4Di, 19.7±0.8 m, n=14; Mann–Whitney test, U=37, n.s., non-significant, p=0.383). (<bold>G</bold>) Top, representative travel paths of each MP group during the light/dark (L/D) box test. Bottom, summary of the CNO effect on the light-zone time (mCherry, 204.9±16.7 s, n=14; hM4Di, 230.2±30.3 s, n=9; Mann–Whitney test, U=57, n.s., non-significant, p=0.73), number of transitions (mCherry, 23.6±1.5, n=14; hM4Di, 30.0±1.9, n=9; Mann–Whitney test, U=28.5, *p=0.028) and total distance (mCherry, 20.0±1.8 m, n=14; hM4Di, 22.7±1.6 m, n=9; Mann–Whitney test, U=34, n.s., non-significant, p=0.072). (<bold>H</bold>) Top, representative images of the marble burying test. Bottom, summary of the effects of CNO treatment on the number of buried marbles (mCherry, 16.1±1.8, n=7; hM4Di, 8.8±1.2, n=9; Mann–Whitney test, U=6.5, **p=0.005). (<bold>I</bold>) Top, schematic of the forced swim test (FST) setup. Bottom, summary of relative time of immobility (mCherry, 61.4 ± 1.9%, n=12; hM4Di, 54.2 ± 2.0%, n=11; Mann–Whitney test, U=29, *p=0.022). (<bold>J</bold>) Top, representative travel paths of each MP group during the three-chamber sociability test. Bottom, summary of the effects of CNO treatment on the social-zone time (mCherry, 46.7 ± 3.7%, n=8; hM4Di, 60.0 ± 3.1%, n=14; Mann–Whitney test, U=22, *p=0.019) and total distance (mCherry, 18.5±1.3 m, n=8; hM4Di, 21.2±2.1 m, n=14; Mann–Whitney test, U=47, n.s., non-significant, p=0.55).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Colocalization of specific somatostatin-expressing (SST) biomarker with virus expression.</title><p>(<bold>A</bold>) Representative images of serial coronal sections. Colocalization of hM4Di-mCherry-expressing (red) and SST-immunoreactive (green) neurons are in yellow. (<bold>B</bold>) Left, distribution of the SST+mCherry/mCherry and SST+mCherry/SST cells along the anterior-posterior (AP) axis. Right, the summary plot of the percentage of the colocalized cells (SST+mCherry/SST, 63.63 ± 3.83%; SST+mCherry/mCherry, 79.68 ± 1.87%; n=18 slice from two mice).</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Suppression of the somatostatin-expressing central nucleus of the amygdala (CeA-SST) neurons increased the withdrawal threshold in the muscle pain (MP) mice.</title><p>(<bold>A</bold>) Experimental schematic and timeline. (<bold>B</bold>) Mice were injected with acidic saline (pH = 4.0) in the left gastrocnemius muscle on the baseline (BL) (day 0) and day 3. Following the pain induction, the withdrawal threshold was continuously monitored for 21 days (MP, n=43, two-way analysis of variance (ANOVA) with Tukey’s post hoc test, F(13,1176)=136.3, <sup>###</sup>p&lt;0.05, ****<sup>,####</sup>p&lt;0.0001 relative to day 14; * indicates the comparison between the ipsilateral hindpaws; <sup>#</sup> indicates the comparison between the contralateral hindpaws. Blue bars indicated clozapine-N-oxide (CNO) application. Gray bars indicated vehicle application).</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig4-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Suppressing somatostatin-expressing central nucleus of the amygdala (CeA-SST) neuron excitability in the Ctrl mice exerted little effect on the nociception and affective behaviors.</title><p>(<bold>A</bold>) Viral constructs and experimental schematic. (<bold>B</bold>) Effect of clozapine-N-oxide (CNO) treatment on the paw withdrawal (PW) threshold in the Ctrl mice (mCherry, n=10; hM4Di, n=15; two-way analysis of variance (ANOVA) with Tukey’s post hoc test, F(9,460) = 1.742, p=0.08). Blue area indicates the period of CNO treatment. (<bold>C</bold>) Left, representative trajectories during the elevated plus maze (EPM) test. Right, summary of the effects of CNO treatment on the open-arm time (mCherry, 21.3 ± 4.2%, n=6; hM4Di, 19.5 ± 1.0%, n=14; Mann–Whitney test, U=34, n.s., non-significant, p=0.545) and total distance (mCherry, 20.7±2.0 m, n=6; hM4Di, 20.1±0.8 m, n=14; Mann–Whitney test, U=37, n.s., non-significant, p=0.716). (<bold>D</bold>) Top, representative travel paths of each Ctrl group during the light/dark (L/D) box test. Bottom, summary of CNO effect on the number of transitions (mCherry, 26.8±2.9, n=4; hM4Di, 31.3±2.2, n=8; Mann–Whitney test, U=9, n.s., non-significant, p=0.259) and total distance (mCherry, 18.7±1.4 m, n=4; hM4Di, 23.0±2.4 m, n=8; Mann–Whitney test, U=6, n.s., non-significant, p=0.105). (<bold>E</bold>) Top, representative images of the marble burying test. Bottom, summary of the effects of CNO treatment on the number of buried marbles (mCherry, 9.0±1.6, n=4; hM4Di, 5.5±0.7, n=8; Mann–Whitney test, U=5.5, n.s., non-significant, p=0.083). (<bold>F</bold>) Top, schematic of the forced swim test (FST) setup. Bottom, summary of relative time of immobility (mCherry, 56.1 ± 2.9%, n=7; hM4Di, 49.2 ± 2.3%, n=9; Mann–Whitney test, U=15, n.s., non-significant, p=0.091). (<bold>G</bold>) Top, representative travel paths during the three-chamber sociability test. Bottom, summary of the effects of CNO treatment on the social-zone time (mCherry, 56.6 ± 5.6%, n=6; hM4Di, 52.0 ± 2.9%, n=13; Mann–Whitney test, U=32, n.s., non-significant, p=0.577) and total distance (mCherry, 19.5±2.7 m, n=6; hM4Di, 21.3±1.8 m, n=13; Mann–Whitney test, U=32, n.s., non-significant, p=0.549).</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig4-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Enhancing central nucleus of the amygdala (CeA)-protein kinase C delta-expressing (PKCδ) neuron excitability reduced pain, but failed to alleviate affective symptoms.</title><p>(<bold>A</bold>) Viral constructs and experimental schematic. Scale bar, 1 mm. (<bold>B</bold>) Top left, representative image of the CeA-PKCδ neurons (green) recognized by an antibody. Top middle, representative image of expression of the hM3Dq-mCherry (red) virus. Top right, overlapping image of the hM3Dq-mCherry and PKCδ antibody signals. Bottom left, distribution of the PKCδ+mCherry/mCherry and PKCδ+mCherry/PKCδ cells along the anterior-posterior (AP) axis. Bottom right, the summary plot of the percentage of the colocalized cells (PKCδ+mCherry/PKCδ, 34.11 ± 1.86%; PKCδ+mCherry/mCherry, 62.73 ± 2.09%; n=21 slice from two mice). (<bold>C</bold>) Top left, overlay of epifluorescence and IR-DIC images showing mCherry(+) neurons in the CeA. Top right, membrane firing frequency changes of an hM3Dq-expressing CeA-PKCδ neurons before and after bath application of clozapine-N-oxide (CNO). Middle, raster plots of hM3Dq(+) and hM3Dq(-) neurons. Blue bar indicates 5 µM CNO application. Bottom, normalized firing frequency in both hM3Dq(+) and hM3Dq(-) neurons (hM3Dq(-), n=5; hM3Dq(+), n=6; two-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test, F(1,189) = 15.23, ***p=0.0001). (<bold>D</bold>) Effect of CNO on the paw withdrawal (PW) threshold in the hM3Dq-MP mice (mCherry, n=5; hM3Dq, n=13; two-way ANOVA with Tukey’s post hoc test, F(9,320) = 47.72, ****p&lt;0.0001 relative to day 14. The blue area indicates the period of CNO treatment). (<bold>E</bold>) Left, representative trajectories of each muscle pain (MP) group during the elevated plus maze (EPM) test. Right, summary of the effects of CNO treatment on open-arm time (mCherry, 17.2 ± 3.9%, n=7; hM3Dq, 13.9 ± 2.3%, n=13; Mann–Whitney test, U=39, n.s., non-significant, p=0.639) and total distance (mCherry, 18.8±1.6 m, n=7; hM3Dq, 20.2±1.3 m, n=13; Mann–Whitney test, U=39, n.s., non-significant, p=0.616). (<bold>F</bold>) Top, representative travel paths of each MP group during the light/dark (L/D) box test. Bottom, summary of CNO effect on the number of transitions (mCherry, 28.3±2.8, n=12; hM3Dq, 37.1±4.4, n=12; Mann–Whitney test, U=38.5, n.s., non-significant, p=0.053) and total distance (mCherry, 16.0±1.8 m, n=12; hM3Dq, 14.0±1.5 m, n=12; Mann–Whitney test, U=51, n.s., non-significant, p=0.239). (<bold>G</bold>) Top, representative images of the marble burying test. Bottom, summary of the effects of CNO treatment on the number of buried marbles (mCherry, 15.8±0.8, n=12; hM3Dq, 16.1±1.2, n=15; Mann–Whitney test, U=74.5, n.s., non-significant, p=0.461). (<bold>H</bold>) Top, schematic of the forced swim test (FST) setup. Bottom, summary of relative time of immobility (mCherry, 51.6 ± 2.8%, n=10; hM3Dq, 63.3 ± 4.2%, n=7; Mann–Whitney test, U=16.5, n.s., non-significant, p=0.074). (<bold>I</bold>) Top, representative travel paths of each MP group during the three-chamber sociability test. Bottom, summary of the effects of CNO treatment on social-zone time (mCherry, 36.1 ± 2.4%, n=7; hM3Dq, 41.6 ± 2.6%, n=10; Mann–Whitney test, U=18, n.s., non-significant, p=0.107) and total distance (mCherry, 26.0±1.0 m, n=7; hM3Dq, 27.3±3.1 m, n=10; Mann–Whitney test, U=26, n.s., non-significant, p=0.414).</p><p><supplementary-material id="fig4s4sdata1"><label>Figure 4—figure supplement 4—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig4-figsupp4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig4-figsupp4-v1.tif"/></fig><fig id="fig4s5" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 5.</label><caption><title>Proposed wiring diagram of central nucleus of the amygdala (CeA) circuits, extrinsic pathways, and behavioral responses.</title><p>(<bold>A–C</bold>) Somatostatin-expressing CeA (CeA-SST) neurons comprise at least two subpopulations. One subpopulation of the CeA-SST neurons (red circle) project to the bed nucleus of the stria terminalis (BNST) for approach-avoidance behaviors, the midbrain ventrolateral periaqueductal gray (vlPAG) for active avoidance behavior, and the lateral habenula (LHb) for depression-like behavior. Furthermore, the CeA-protein kinase C delta-expressing (PKCδ) neurons also establish reciprocal inhibition with another subpopulation of the CeA-SST neurons (red square) and project to the major output of the CeA, which is the medial division of the CeA (CeM) region, and then project to the PAG region for pain behavior. Both CeA-SST and CeA-PKCδ neuron subpopulations receive input from the parabrachial nucleus (PBN), basolateral amygdala (BLA), and paraventricular thalamus (PVT). (<bold>A</bold>) Normal condition; (<bold>B</bold>) muscle pain (MP) state; (<bold>C</bold>) treated state after chemogenetic inactivation of the CeA-SST neurons or activation of the CeA-PKCδ neurons or after pregabalin (PGB) treatment.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig4-figsupp5-v1.tif"/></fig></fig-group><p>Next, we tested the causal role of the CeA-SST neurons in MP-associated behaviors. CNO was i.p. injected into the mice following the establishment of MP (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). We found that inhibiting the CeA-SST neurons in the MP mice 2 weeks following MP induction was still effective in increasing the PW threshold on day 15 (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), and the pain-reduction effect lasted for 24 hr and persisted if CNO was administered repeatedly (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). On the same day following the CNO injection, we also tested the effect of inhibiting the CeA-SST neurons on the affective symptoms. Compared to the mCherry-MP mice, the hM4Di-MP mice spent more time in the open arms during the EPM test (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), exhibited increased transitions between light and dark zones in the L/D box test (<xref ref-type="fig" rid="fig4">Figure 4G</xref>), buried fewer marbles in the marble burying test (<xref ref-type="fig" rid="fig4">Figure 4H</xref>), and immobilized less in the FST (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Moreover, the hM4Di-MP mice spent more time in the social zone in the three-chamber sociability test (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). However, the total travel distances of the mCherry-MP and hM4Di-MP mice were not significantly different (<xref ref-type="fig" rid="fig4">Figure 4F, G and J</xref>). Notably, chemogenetic inhibition of the CeA-SST neurons in the hM4Di-Ctrl mice had little effects on the PW threshold and on their respective performances in the EPM, L/D box, marble burying test, FST, and sociability test (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). Collectively, these observations suggest that inactivating the CeA-SST neurons selectively reduced pain and alleviated the anxiety- and depression-like behaviors in the MP mice.</p><p>Both enhanced CeA-SST and decreased CeA-PKCδ neuronal activity were observed in the MP mice. These two types of neurons reciprocally inhibit each other. We subsequently tested whether increasing CeA-PKCδ neuronal activity could also reduce mechanical hyperalgesia and anxiety-like behaviors. The excitatory designer receptor (hM3Dq) was virally expressed in the CeA-PKCδ neurons (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4A</xref>). Most of the hM3Dq-expressing cells, as identified by the mCherry expression, were immunoreactive for PKCδ (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4B</xref>). Whole-cell current-clamp recordings demonstrated that bath application of CNO (5 μM) selectively enhanced spontaneous firing in the hM3Dq-expressing CeA-PKCδ neurons as compared to the mCherry-expressing CeA-PKCδ neurons (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4C</xref>). Like the silencing of the hM4Di-expressing CeA-SST neurons, the activation of the hM3Dq-expressing CeA-PKCδ neurons greatly increased the PW threshold in the MP mice (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4D</xref>). Intriguingly, unlike the results of inactivating the CeA-SST neurons, enhancing the CeA-PKCδ neurons had little effect on the anxiety-like behaviors. There were no changes in the open-arm time (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4E</xref>), number of transitions during the L/D box test (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4F</xref>), and number of buried marbles (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4G</xref>). Similarly, enhancing the CeA-PKCδ neurons did not improve depression-like behavior (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4H</xref>) and sociability (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4I</xref>). Taken together, these results suggest that activation of the CeA-PKCδ neurons is sufficient to reduce mechanical hyperalgesia in the MP mice. However, changes in the excitability of the CeA-PKCδ neurons were not causally related to MP-related affective behaviors.</p></sec><sec id="s2-5"><title>PGB suppressed the CeA-SST neuron excitability and nociceptive transmission onto the CeA-SST neurons</title><p>Since enhanced CeA-SST neuronal activity was observed in the MP mice, we tested the effect of PGB on excitatory synaptic transmission onto the CeA-SST neurons. To this end, we injected an AAV5-CaMKIIα-ChR2-eYFP virus into the PBN of the SST-Cre;Ai14 mice. Four weeks later, these mice were randomly included as either the Ctrl or MP mice (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Using the optogenetic stimulation, we recorded light-evoked EPSCs from the CeA-SST neurons of the Ctrl or MP mice in response to short light (470 nm, 5 ms) illumination to PBN terminals in the CeA region (<xref ref-type="fig" rid="fig5">Figure 5B</xref>; Ctrl, left; MP, right). Bath application of PGB (500 µM) decreased the amplitude of light-evoked EPSCs in some CeA-SST neurons of both the Ctrl and MP mice (<xref ref-type="fig" rid="fig5">Figure 5B and D</xref>). The percentage of neurons that were sensitive to PGB inhibition was increased in the MP mice (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, left), although the degree of inhibition between these two groups was similar (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, right). Consistent with the presynaptic effect of PGB on α2δ VGCC subunits, the reduction of EPSCs was concomitant with an increase in the paired-pulse ratio (the interpulse interval = 200 ms; <xref ref-type="fig" rid="fig5">Figure 5E</xref>). Similar effects of PGB on synaptic transmission were found at the PBN to CeA-PKCδ neuron synapses (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Pregabalin (PGB) suppressed the somatostatin-expressing central nucleus of the amygdala (CeA-SST) neuron excitability and glutamate release from the parabrachial nucleus (PBN) to the CeA-SST neurons.</title><p>(<bold>A</bold>) Experimental schematic and timeline. (<bold>B</bold>) Left, amplitude of the light-evoked excitatory postsynaptic currents (EPSCs) before and after PGB application of CeA-SST neurons in a representative Ctrl mouse. Right, amplitude of the light-evoked EPSCs before and after PGB application of the CeA-SST neurons in a representative muscle pain (MP) mouse; traces of EPSCs of the cell are shown above. (<bold>C</bold>) Left, pie chart showing the percentage of inhibition neurons after PGB treatment (Ctrl, 37%, n=8 cells from 5 mice; MP, 63%, n=8 cells from 4 mice; Chi-square test, p=0.317). Right, percentage of EPSC inhibition of PGB-sensitive neurons in the Ctrl and MP groups (Ctrl, 24.9 ± 5.3%, n=3; MP, 30.1 ± 5.5%, n=5; Mann–Whitney test, U=5, n.s., non-significant, p=0.5). (<bold>D</bold>) Cells with EPSC inhibition &gt;×1 SD<sub>BL</sub> are pooled and plotted for the normalized EPSCs over time (Ctrl, n=3; MP, n=5). (<bold>E</bold>) Top, representative EPSC traces before (black) and 10 min after PGB application (red). Average trace after PGB application is normalized to the peak of average EPSC trace during baseline (BL). Paired-pulse interval = 200 ms. Bottom, summary of paired-pulse ratio (PPR) of cells shown in (<bold>D</bold>) before and after PGB application (BL, 0.58±0.03, n=8; PGB, 0.65±0.04, n=8; gray circle: Ctrl group; orange circle: MP group; Wilcoxon matched-pairs signed rank test, **p=0.008). (<bold>F</bold>) Left and bottom, experimental schematic and timeline. Right, representative image of CeA-SST neurons labeled with GCaMP6s. Cells with their calcium traces shown in the panel G were labeled. (<bold>G</bold>) Representative traces from cells of interest (color-matched in the panel F right). (<bold>H</bold>) The frequency of calcium events for CeA-SST neurons before and after PGB i.p. injection (BL, 0.036±0.003 Hz; PGB, 0.023±0.003 Hz, n=46 cells from three mice; Wilcoxon matched-pairs signed rank test, **p=0.004) and the percentage of ΔF/F before and after PGB i.p. injection (BL, 34.1 ± 2.8%; PGB, 26.4 ± 2.7%, n=46 cells from three mice; Wilcoxon matched-pairs signed rank test, *p=0.045). (<bold>I</bold>) The area under the curve (AUC) of calcium traces of CeA-SST neurons before and after PGB application. Neurons with ΔAUC &lt; (0.02 a.u./s) were distributed within two dashed lines. Pie chart, the percentage of neuronal responses after PGB treatment (n=46 cells). (<bold>J</bold>) The heatmaps of normalized calcium activities before and after the PGB treatment. Neurons were grouped based on the classification in (<bold>I</bold>).</p><p><supplementary-material id="fig5scode1"><label>Figure 5—source code 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig5">Figure 5I and J</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78610-fig5-code1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Effect of pregabalin (PGB) on neurotransmission at the parabrachial nucleus (PBN) to the central nucleus of the amygdala (CeA)-protein kinase C delta-expressing (PKCδ) neuron synapses.</title><p>(<bold>A</bold>) Experimental schematic and timeline. (<bold>B</bold>) Left, amplitude of light-evoked excitatory postsynaptic currents (EPSCs) before and after PGB application of the CeA-PKCδ neurons in the Ctrl mice. Right, amplitude of light-evoked EPSCs before and after PGB application of the CeA-PKCδ neurons in the muscle pain (MP) mice; traces of EPSCs of the cell are shown above. (<bold>C</bold>) Left, pie chart showing the percentage of inhibition neurons after PGB treatment (Ctrl, 30%, n=10 cells from five mice; MP, 63%, n=8 cells from four mice; Chi-square test, p=0.1679). Right, percentage of EPSC inhibition of Ctrl and MP groups (Ctrl, 23.5 ± 8.3%, n=3; MP, 34.6 ± 5.7%, n=5; Mann–Whitney test, U=3, n.s., non-significant, p=0.25). (<bold>D</bold>) Cells with EPSC inhibition &gt;×1 SD<sub>BL</sub> are pooled and plotted for the normalized EPSCs over time (Ctrl, n=3; MP, n=5). (<bold>E</bold>) Top, representative EPSC traces before and 10 min after PGB application. Average trace after PGB application is normalized to the peak of average EPSC trace during baseline (BL). Paired-pulse interval = 100 ms. Bottom, summary of paired-pulse ratio (PPR) of cells shown in (<bold>D</bold>) before and after PGB application (BL, 0.43±0.06, n=8; PGB, 0.53±0.08, n=8; gray circle: Ctrl group; orange circle: MP group; Wilcoxon matched-pairs signed rank test, *p=0.039).</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Comparison of light-evoked excitatory postsynaptic current (EPSC) amplitude and paired-pulse ratio (PPR) at the parabrachial nucleus (PBN) to the central nucleus of the amygdala (CeA) neuron synapses.</title><p>(<bold>A</bold>) The amplitude of the light-evoked EPSCs recorded at the PBN-CeA-SST neuron synapses in the Ctrl and muscle pain (MP) groups (Ctrl, 73.9±17.9 pA, n=8; MP, 110.7±20.0 pA, n=8; Mann–Whitney test, U=17, n.s., non-significant, p=0.13). (<bold>B</bold>) The PPR of the light-evoked EPSCs recorded at the PBN-CeA-SST neuron synapses in the Ctrl and MP groups (Ctrl, 0.65±0.04, n=8; MP, 0.60±0.02, n=8; Mann–Whitney test, U=25, n.s., non-significant, p=0.49). (<bold>C</bold>) The amplitude of the light-evoked EPSCs recorded at the PBN-CeA-PKCδ neuron synapses in the Ctrl and MP groups (Ctrl, 134.2±13.2 pA, n=10; MP, 75.7±14.5 pA, n=8; Mann–Whitney test, U=12, *p=0.01). (<bold>D</bold>) The PPR of the light-evoked EPSCs recorded at the PBN-CeA-PKCδ neuron synapses in the Ctrl and MP groups (Ctrl, 0.62±0.06, n=10; MP, 0.52±0.08, n=8; Mann–Whitney test, U=28, n.s., non-significant, p=0.31). (<bold>E</bold>) The amplitude of the light-evoked EPSCs recorded at the PBN-CeA-PKCδ neuron synapses and PBN-CeA-SST neuron synapses in the Ctrl mice (SST, 73.9±17.9 pA, n=8; PKCδ, 134.2±13.2 pA, n=10; Mann–Whitney test, U=13, *p=0.016). (<bold>F</bold>) The amplitude of the light-evoked EPSCs recorded at the PBN-CeA-PKCδ neuron synapses and PBN-CeA-SST neuron synapses in the MP mice (SST, 110.7±20.0 pA, n=8; PKCδ, 75.7±14.5 pA, n=8; Mann–Whitney test, U=19, p=0.19). (<bold>G</bold>) The PPR of the light-evoked EPSCs recorded at the PBN-CeA-PKCδ neuron synapses and PBN-CeA-SST neuron synapses in the Ctrl mice (SST, 0.65±0.04, n=8; PKCδ, 0.62±0.06, n=10; Mann–Whitney test, U=18, n.s., non-significant, p=0.054). (<bold>H</bold>) The PPR of the light-evoked EPSCs recorded at the PBN-CeA-PKCδ neuron synapses and PBN-CeA-SST neuron synapses in the MP mice (SST, 0.60±0.02, n=8; PKCδ, 0.52±0.08, n=8; Mann–Whitney test, U=28, n.s., non-significant, p=0.7).</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Numerical data to support the graphs in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-78610-fig5-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78610-fig5-figsupp2-v1.tif"/></fig></fig-group><p>Finally, we tested whether intraperitoneal injection of PGB suppresses the CeA-SST neuron activity using in vivo calcium imaging. To selectively detect the calcium activities of the CeA-SST neurons, the SST-Cre mice were virally transduced to express the calcium indicator GCaMP6s and implanted with the GRIN lens above the CeA for 4 weeks before the test. Calcium activities of single CeA-SST neurons were detected before and 45 min following intraperitoneal injection of PGB (30 mg/kg; <xref ref-type="fig" rid="fig5">Figure 5F</xref>), which is known to significantly increase the mechanical threshold of the hindpaws in this MP model (<xref ref-type="bibr" rid="bib57">Yokoyama et al., 2007</xref>). After intraperitoneal injection of PGB, the CeA-SST neurons exhibited decreased calcium event frequency (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>, left) and mean amplitude (ΔF/F; <xref ref-type="fig" rid="fig5">Figure 5G and H</xref>, right). The analysis of the area under the curve (AUC) of spontaneous calcium activities suggested that approximately 56% (26/46 cells) of CeA-SST neurons were inhibited, 11% (5/46 cells) of CeA-SST neurons were excited, and 33% of (15/46 cells) CeA-SST neurons were insensitive to PGB application (<xref ref-type="fig" rid="fig5">Figure 5I and J</xref>). Taken together, these results suggest that PGB suppressed glutamate transmission onto the CeA-SST neurons, thereby reducing mechanical allodynia and reversed anxiety- and depression-like behaviors in the MP mice.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we explored the role of the CeA neurons in central sensitization of chronic pain using the acid-induced MP model. This model developed by <xref ref-type="bibr" rid="bib47">Sluka et al., 2001</xref> is a generally accepted preclinical animal model for chronic musculoskeletal pain syndrome. The second acidic saline injection during the hyperalgesic priming promoted pain chronification. Local PGB application into the CeA reduced mechanical allodynia and reversed affective behaviors in the MP mice. Intriguingly, intra-CeA PGB application or selective inactivation of CeA-SST neurons immediately following the second acidic saline injection prevented the chronification of pain. Notably, the MP was accompanied by enhanced glutamatergic transmission onto the CeA-SST neurons and decreased synaptic transmission onto the CeA-PKCδ neurons. Furthermore, the CeA-SST neuron excitability and CeA-PKCδ neuron excitability was increased and decreased, respectively. In agreement with the role of CeA-SST neurons in central sensitization, chemogenetic inactivation or pharmacological suppression of the CeA-SST neurons by PGB effectively alleviated MP and comorbid affective behaviors.</p><sec id="s3-1"><title>Effect of PGB on pain and emotional behaviors</title><p>The effect of PGB on the PW threshold could be replicated by either reducing or elevating the CeA-SST and CeA-PKCδ neuron activities, respectively; however, this is not the case for the anxiety-like affective behaviors. Therefore, the effect of PGB on the PW threshold and emotional behaviors in the MP mouse model may be caused by distinct simultaneously occurring circuit mechanisms. To further elucidate this, we plotted the changes of the immobility time in the FST or number of buried marbles in the marble burying test against the change of mechano-sensitivity to examine the effect of PGB on pain sensitivity and emotional behaviors. Only the data obtained from the FST and marble burying test were used to examine the effect of PGB on the pain sensitivity and emotional behaviors because these two behavioral assays could be tested before and after PGB application on the same animals. After PGB application, no positive correlation was observed between the increase in the PW threshold and the reduction of the immobility time. On the other hand, only a weak positive correlation between the change of PW threshold and change in the number of buried marbles was detected (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). These results indicate that PGB may alleviate the mechano-sensitivity and emotional behavior through different subtypes of the CeA-SST neurons or distinct circuit mechanisms (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>; see Discussion).</p></sec><sec id="s3-2"><title>Maladaptive rewiring of glutamatergic synapses onto the CeA neurons</title><p>Synaptic modifications and changes of intrinsic excitability play a crucial role in health and disease (<xref ref-type="bibr" rid="bib6">Bliss et al., 2014</xref>; <xref ref-type="bibr" rid="bib21">Fu et al., 2008</xref>; <xref ref-type="bibr" rid="bib30">Ikeda et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Kuner and Flor, 2016</xref>; <xref ref-type="bibr" rid="bib44">Penzo et al., 2015</xref>). The formation of long-term potentiation at the synapses in pain-related brain regions is considered one of the synaptic mechanisms underlying the transition of acute to chronic MP (<xref ref-type="bibr" rid="bib41">Min et al., 2011</xref>). The protein kinase C (PKC)-extracellular signal-regulated kinase (ERK) pathway plays a key role in the maladaptive changes in the neural circuitry of the MP mice (<xref ref-type="bibr" rid="bib11">Chen et al., 2010</xref>; <xref ref-type="bibr" rid="bib14">Cheng et al., 2011</xref>; <xref ref-type="bibr" rid="bib41">Min et al., 2011</xref>). For instance, MP is associated with enhanced pERK expression in the paraventricular thalamus (PVT) and CeA (<xref ref-type="bibr" rid="bib11">Chen et al., 2010</xref>; <xref ref-type="bibr" rid="bib14">Cheng et al., 2011</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). The PVT, a structure that is readily activated by both physical and psychological stressors, projects to the CeA (<xref ref-type="bibr" rid="bib44">Penzo et al., 2015</xref>). Several studies supported the involvement of the PKC and/or ERK activity in these two brain regions. First, inhibition of the PKC or ERK activity in the PVT, a major input to the CeA, prevents the chronification of pain (<xref ref-type="bibr" rid="bib11">Chen et al., 2010</xref>). Second, upregulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors function at the PBN-capsular central amygdala neurons (CeAC) synapse in the MP mice requires the activation of the PKC-mitogen-activated protein kinase (MEK)-ERK pathway in the CeAC neurons (<xref ref-type="bibr" rid="bib14">Cheng et al., 2011</xref>). Finally, PKC-dependent, but ERK-independent, enhancement of synaptic release occurs at the PBN-CeAC synapses in the MP mice (<xref ref-type="bibr" rid="bib14">Cheng et al., 2011</xref>).</p><p>Here, we reported an increase in the sEPSC and mEPSC frequencies but not their amplitudes in the CeA-SST neurons. The EPSCs and PPR at the PBN-CeA-SST neuron synapses were not significantly altered in the MP mice compared to the Ctrl mice (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>), suggesting other possible inputs, which may contribute to increased spontaneous synaptic events. Several excitatory inputs impinge onto CeA neurons (<xref ref-type="bibr" rid="bib20">Fadok et al., 2018</xref>). The CeA receives nociceptive inputs from the dorsal horn via the PBN and affect-related information from the basolateral amygdala (BLA) (<xref ref-type="bibr" rid="bib30">Ikeda et al., 2007</xref>; <xref ref-type="bibr" rid="bib35">Kuner and Kuner, 2021</xref>; <xref ref-type="bibr" rid="bib38">Li and Sheets, 2020</xref>; <xref ref-type="bibr" rid="bib54">Wilson et al., 2019</xref>). Additionally, the PVT, which is a structure that is readily activated by both physical and psychological stressors, projects onto the CeA (<xref ref-type="bibr" rid="bib44">Penzo et al., 2015</xref>). The sEPSC decay time analysis revealed at least two populations of sEPSCs, suggesting heterogeneous excitatory inputs impinging on different spatial domains of the CeA neuron dendrites (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). Previous studies have reported that synaptic inputs from the PVT and BLA onto the CeA are strengthened in chronic pain conditions (<xref ref-type="bibr" rid="bib30">Ikeda et al., 2007</xref>; <xref ref-type="bibr" rid="bib39">Liang et al., 2020</xref>). Considering the role of ERK in the PVT for MP (<xref ref-type="bibr" rid="bib11">Chen et al., 2010</xref>), the PVT input most likely contributes to the enhancement of glutamate release to the CeA-SST neurons in the MP mice. Moreover, we cannot exclude the contribution of the BLA input, because BLA-CeA synapses are potentiated in chronic neuropathic pain (<xref ref-type="bibr" rid="bib30">Ikeda et al., 2007</xref>).</p><p>In addition to synaptic plasticity, ERK is probably involved in the cell-intrinsic mechanisms. Considering that pERK is increased in CeA-SST neurons in the MP mice (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), we speculate that the ERK activity may contribute to the increase in intrinsic neuronal excitability of the CeA-SST neurons in the MP mice. The CaMKII-PKA/PKC-ERK-cAMP response element binding protein (CREB) pathway triggers gene transcription and protein synthesis (<xref ref-type="bibr" rid="bib33">Kolch, 2000</xref>). The activated ERK1/2 can undergo phosphorylation after translocating to the nucleus and then activate the downstream transcriptional factor CREB (<xref ref-type="bibr" rid="bib31">Iyengar et al., 2017</xref>). Activation of CREB triggers gene transcription and plasticity including regulation of a variety of ion channels, thereby changing the AP threshold and neuronal excitability (<xref ref-type="bibr" rid="bib18">Dong et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Zhou et al., 2009</xref>). For instance, downregulation of A-type K<sup>+</sup> channels such as K<sub>v</sub>4.2 expression or upregulation of the voltage-gated Na channels such as Na<sub>v</sub>1.3 and Na<sub>v</sub>1.7 expressions can either decrease the rheobase or increase action potential numbers (<xref ref-type="bibr" rid="bib4">Bennett et al., 2019</xref>; <xref ref-type="bibr" rid="bib27">Hu and Gereau, 2003</xref>).</p></sec><sec id="s3-3"><title>Subtype of sensitized CeA neurons depends on the mouse model of chronic pain</title><p>A recent study by <xref ref-type="bibr" rid="bib54">Wilson et al., 2019</xref>, demonstrated that neuropathic pain-induced activated forms of ERK (pERK) and cFos were preferentially expressed in the CeA-PKCδ neurons, which exhibited enhanced excitability relative to the CeA-SST neurons. Furthermore, chemogenetic silencing of CeA-PKCδ neurons or activation of the CeA-SST neurons reversed nerve-injury-induced hyperalgesia (<xref ref-type="bibr" rid="bib54">Wilson et al., 2019</xref>). Similarly, another study demonstrated that chemogenetic inhibition of the CeA-PKCδ neurons reduced mechanical hyperalgesia in mice with formalin-induced pain (<xref ref-type="bibr" rid="bib13">Chen et al., 2022</xref>). However, two recent studies contradicted this notion (<xref ref-type="bibr" rid="bib28">Hua et al., 2020</xref>; <xref ref-type="bibr" rid="bib59">Zhou et al., 2019</xref>). Using the spared nerve injury model, Zhou and colleagues demonstrated that a small population of CeA-SST neurons, which are glutamatergic and project to the lateral habenula (LHb), exhibited enhanced excitability and were involved in a neural circuit for hyperalgesia and comorbid depressive symptoms (<xref ref-type="bibr" rid="bib59">Zhou et al., 2019</xref>). Moreover, a subpopulation of neurons co-expressing PKCδ and enkephalin confined to the mid-posterior axis of the CeA was shown to mediate the antinociceptive function in response to general anesthetics (<xref ref-type="bibr" rid="bib28">Hua et al., 2020</xref>). In the present study, using the acid-induced MP model, we observed that chemogenetic inactivation of the CeA-SST neurons effectively alleviated MP and comorbid affective behaviors. Overall, the subtype of sensitized neurons in the CeA may vary based on the chronic pain models.</p></sec><sec id="s3-4"><title>The CeA contains functionally distinct neuronal populations</title><p>CeA-SST neurons form reciprocal connections with CeA-PKCδ neurons (<xref ref-type="bibr" rid="bib15">Ciocchi et al., 2010</xref>; <xref ref-type="bibr" rid="bib23">Haubensak et al., 2010</xref>). Notably, silencing the CeA-SST neurons in the MP model improved affective behaviors, while activating the CeA-PKCδ neurons had little effect on them. Our results support a notion that the CeA-SST neurons contain heterogeneous subpopulations (<xref ref-type="bibr" rid="bib43">Penzo et al., 2014</xref>). The CeA-SST neurons could comprise at least two distinct subtypes of pro-nociceptive neurons based on their intrinsic firing properties and downstream targets in the MP model. A subset of the CeA-SST neurons could project onto the bed nucleus of the stria terminalis for approach-avoidance behavior, the midbrain ventrolateral periaqueductal gray for active-avoidance behavior, and the LHb for depression-like behavior. We speculate that the CeA-PKCδ neurons could inhibit the other subset of the CeA-SST neurons, which form reciprocal inhibition with the CeA-PKCδ neurons. In agreement with this hypothesis, chemogenetic activation of CeA-PKCδ neurons reduced tactile allodynia without influencing affective behaviors in MP. Notably, investigations on pain-related affective comorbidities at the cellular level between these two neurons have not been reported in the acid-induced MP model. Nevertheless, the neural mechanisms by which the CeA-SST neurons and their downstream targets regulate negative affect have been characterized (<xref ref-type="bibr" rid="bib1">Ahrens et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Haubensak et al., 2010</xref>; <xref ref-type="bibr" rid="bib37">Li et al., 2013</xref>; <xref ref-type="bibr" rid="bib59">Zhou et al., 2019</xref>). Therefore, the hyperexcitability of the CeA-SST neurons and the resulting affective symptoms can be well explained by the downstream pathways of the CeA-SST neurons (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>).</p><p>A potential caveat of this study is that single molecular markers such as SST or PKCδ may not be specific enough to identify functionally distinct CeA neuronal populations in the modulation of pain. For instance, these neurons display different intrinsic properties such as firing phenotypes (<xref ref-type="bibr" rid="bib26">Hou et al., 2016</xref>). According to our previous study (<xref ref-type="bibr" rid="bib26">Hou et al., 2016</xref>), we analyzed the CeA neurons shown in <xref ref-type="fig" rid="fig3">Figure 3</xref> and classified them into early-spiking (ES) and late-spiking (LS) neurons based on their spike delay at rheobase. Using the same criteria, the CeA neurons with a spike delay greater than 1.5 s were classified as LS neurons, whereas the rest were classified as ES neurons. The ratio of these two subpopulations (ES vs. LS subtype) in either CeA-SST or CeA-PKCδ neurons was not significantly altered in the MP mice (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>). However, in the MP mice, the enhanced excitatory transmission was specific to the CeA-SST-ES neurons, whereas the depressed excitatory transmission was specific to the CeA-PKCδ-LS neurons. On the other hand, the modification of cell excitability in the MP mice was specific to ES neurons in both the CeA-SST and CeA-PKCδ neurons (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>).</p><p>To achieve greater specificity, composite molecular markers and/or anatomical locations should be considered. A single molecularly defined population can be further divided based on its location within a brain area (<xref ref-type="bibr" rid="bib38">Li and Sheets, 2020</xref>; <xref ref-type="bibr" rid="bib54">Wilson et al., 2019</xref>). For example, spared nerve injury distinctly alters inputs from the PBN to the SST neurons based on their location in the lateral division of the CeA (CeL). Notably, the input from the PBN to the SST neurons in the capsular division of the CeA (CeC) is depressed, whereas the same input to the SST neurons in the CeL and the medial division of the CeA (CeM) is not altered. Moreover, our recent study (<xref ref-type="bibr" rid="bib26">Hou et al., 2016</xref>) reported that the CeA-SST neurons exhibit a high degree of variation in the spike delay in response to the current injection in the slice recording and added an additional layer of heterogeneity. Considering the distinct synaptic and cellular properties of these subpopulations, they are likely to react differently to chemogenetic manipulations. Thus, while the entire molecularly defined neuronal population is targeted for manipulations, the net effects are likely to be dominated by the subpopulations that are preferentially expressed with optogenetic or chemogenetic actuators. Thus, a novel toolkit integrating anatomical, physiological, and molecular profiles of single neurons is warranted for functional dissection of CeA microcircuitry.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (mouse, male and female)</td><td align="left" valign="bottom"><italic>Sst <sup>tm2.1(cre)Zjh</sup></italic>/J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX">IMSR_JAX</ext-link>: 013044</td><td align="left" valign="bottom">C57BL/6J genetic background</td></tr><tr><td align="left" valign="bottom">Strain, strain background (mouse, male and female)</td><td align="left" valign="bottom">Tg(Prkcd-glc-1/CFP,-cre)EH124Gsat/Mmucd</td><td align="left" valign="bottom">Mutant Mouse Resource and Research Center</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MMRRC_011559-UCD">MMRRC_011559-UCD</ext-link></td><td align="left" valign="bottom">C57BL/6J genetic background</td></tr><tr><td align="left" valign="bottom">Strain, strain background (mouse, male and female)</td><td align="left" valign="bottom">B6.Cg-Gt(ROSA)26Sor<sup>tm14 (CAG-tdTomato)Hze</sup>/J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX">IMSR_JAX</ext-link>:<break/>007914</td><td align="left" valign="bottom">C57BL/6J genetic background</td></tr><tr><td align="left" valign="bottom">Strain, strain background (mouse, male and female)</td><td align="left" valign="bottom">C57BL/6JNarl</td><td align="left" valign="bottom">National Laboratory Animal Center (Taiwan)</td><td align="left" valign="bottom">RMRC11005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-RFP (rabbit polyclonal)</td><td align="left" valign="bottom">Rockland</td><td align="left" valign="bottom">Cat#: 600-401-379S; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11182807">AB_11182807</ext-link></td><td align="char" char="." valign="bottom">1:300</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-PKCδ (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: ab182126; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2892154">AB_2892154</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat anti-SST (rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: ab30788; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_778010">AB_778010</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit Alexa Fluor 488 (rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#: A27034; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2536097">AB_2536097</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit Alexa Fluor 594 (rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#: A-11012; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534079">AB_2534079</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rat Alexa Fluor 488 (rat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#: A-11006; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534074">AB_2534074</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AAV5-hSyn-DIO-mCherry</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_50459">Addgene_50459</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AAV5-hSyn-DIO- hM3Dq-mCherry</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_44361">Addgene_44361</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AAV5-hSyn-DIO-hM4Di-mCherry</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_44362">Addgene_44362</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AAV5-CaMKIIα-ChR2-eYFP</td><td align="left" valign="bottom">University of North Carolina Vector Core</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AAV5-Syn-Flex-GCaMP6s-WPRE-SV40</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_100845">Addgene_100845</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MES hydrate</td><td align="left" valign="bottom">MERCK</td><td align="left" valign="bottom">M2933</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Clozapine-N-oxide</td><td align="left" valign="bottom">MERCK</td><td align="left" valign="bottom">C0832</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SR 95531</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab120042</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CGP 55845</td><td align="left" valign="bottom">Tocris</td><td align="char" char="." valign="bottom">1248</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Kynurenic acid</td><td align="left" valign="bottom">MERCK</td><td align="left" valign="bottom">K3375</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tetrodotoxin citrate</td><td align="left" valign="bottom">Tocris</td><td align="char" char="." valign="bottom">1069</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Pregabalin</td><td align="left" valign="bottom">Pfizer</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Tru-scan 2.0 system</td><td align="left" valign="bottom">Coulbourn instruments</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.coulbourn.com/category_s/262.htm">https://www.coulbourn.com/category_s/262.htm</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">EthoVision XT 13</td><td align="left" valign="bottom">Noldus Information Technology</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000441">SCR_000441</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.noldus.com/ethovision-xt">https://www.noldus.com/ethovision-xt</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">pClamp and Clampfit 10.3</td><td align="left" valign="bottom">Molecular Devices</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011323">SCR_011323</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.moleculardevices.com/">https://www.moleculardevices.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 6</td><td align="left" valign="bottom">GraphPad Software</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MiniAnalysis v6.0.9</td><td align="left" valign="bottom">Synaptosoft</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002184">SCR_002184</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.synaptosoft.com/MiniAnalysis/">http://www.synaptosoft.com/MiniAnalysis/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Python</td><td align="left" valign="bottom">Jupyter notebook</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008394">SCR_008394</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://jupyter.org/">https://jupyter.org/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ (Fiji)</td><td align="left" valign="bottom">National Institutes of Health (NIH)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji/Downloads">https://imagej.net/Fiji/Downloads</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Coreldraw X8</td><td align="left" valign="bottom">CorelDRAW</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014235">SCR_014235</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.coreldraw.com/en/?trial-delay=none">https://www.coreldraw.com/en/?trial-delay=none</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Inscopix data processing v1.6.0</td><td align="left" valign="bottom">Inscopix</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.inscopix.com/software-analysis">https://www.inscopix.com/software-analysis</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Microsyringe 10 μL</td><td align="left" valign="bottom">World Precision Instruments</td><td align="left" valign="bottom">NANOFIL</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.wpiinc.com/">https://www.wpiinc.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">34 G beveled NanoFil needle</td><td align="left" valign="bottom">World Precision Instruments</td><td align="left" valign="bottom">NF34BV-2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.wpiinc.com/">https://www.wpiinc.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Animal temperature controller</td><td align="left" valign="bottom">Physitemp Instruments</td><td align="left" valign="bottom">TCAT-2LV</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://physitemp.com/">https://physitemp.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Microsyringe pump controller</td><td align="left" valign="bottom">KD Scientific</td><td align="left" valign="bottom">KDS310</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.kdscientific.com/">https://www.kdscientific.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Cryostat</td><td align="left" valign="bottom">Leica</td><td align="left" valign="bottom">CM1900; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_020218">SCR_020218</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.leicabiosystems.com/zh/">https://www.leicabiosystems.com/zh/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Microslicer</td><td align="left" valign="bottom">Dosaka</td><td align="left" valign="bottom">DTK-1000</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.dosaka-em.jp/products/280/">http://www.dosaka-em.jp/products/280/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Axopatch 200B patch clamp amplifier</td><td align="left" valign="bottom">Molecular Devices</td><td align="left" valign="bottom">Axopatch 200B; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018866">SCR_018866</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.moleculardevices.com/">https://www.moleculardevices.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Digitizer</td><td align="left" valign="bottom">Molecular Devices</td><td align="left" valign="bottom">Digidata 1440A; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_021038">SCR_021038</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.moleculardevices.com/">https://www.moleculardevices.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Borosilicate glass with filament</td><td align="left" valign="bottom">Harvard Apparatus</td><td align="left" valign="bottom">GC150F-7.5</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.warneronline.com/clark-borosilicate-standard-wall-with-filament">https://www.warneronline.com/clark-borosilicate-standard-wall-with-filament</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Cannula</td><td align="left" valign="bottom">RWD Life Science</td><td align="left" valign="bottom">Guide cannula: 0.41 mm in diameter and 5 mm long; Dummy cannula: 0.2 mm in diameter and 5.5 mm long</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.rwdstco.com/product-item/single-cannula/">https://www.rwdstco.com/product-item/single-cannula/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">ProView integrated lens</td><td align="left" valign="bottom">Inscopix</td><td align="left" valign="bottom">Diameter, 0.5 mm; length, 6.1 mm</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.inscopix.com/lenses-viruses">https://www.inscopix.com/lenses-viruses</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Miniscope system</td><td align="left" valign="bottom">Inscopix</td><td align="left" valign="bottom">nVista 3.0; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017407">SCR_017407</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.inscopix.com/nvista">https://www.inscopix.com/nvista</ext-link></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>Four transgenic mouse lines were used in this study: SST-Cre (stock number [no.] 013044), SST-Cre;Ai14 (SST-Cre line crossed with Ai14 line), PKCδ-Cre (stock no. 011559), and PKCδ-Cre;Ai14 (PKCδ-Cre line crossed with Ai14 line). The SST-Cre line and Ai14 tdTomato reporter (stock no. 007914) were purchased from the Jackson Laboratory. PKCδ-Cre and C57BL/6J mice were purchased from the Mutant Mouse Resource and Research Centers (MMRRC) and National Laboratory Animal Center, respectively. Mice aged 2–5 months of either sex were used in the electrophysiological and behavioral studies. All the mice were bred against the C57BL/6J genetic background. Mice were housed in a 12 hr light-dark cycle and provided food and water ad libitum. Two-month-old mice were injected with a virus and implanted with optical fibers in the CeA. The animals were handled in accordance with national and institutional guidelines. All behavioral procedures were conducted in accordance with the protocol (no. 1080317) approved by the Institutional Animal Care and Use Committee of the National Yang Ming Chiao Tung University.</p></sec><sec id="s4-2"><title>Viruses</title><p>To specifically express designer receptors exclusively activated by designer drugs (DREADDs) onto the CeA-SST and CeA-PKCδ neurons, we used a recombinant AAV5 carrying hM3Dq or hM4Di conjugated to mCherry in a double-floxed inverted open reading frame (DIO), driven by the human Synapsin I (hSyn) promoter (AAV5-hSyn-DIO-hM3Dq-mCherry or AAV5-hSyn-DIO-hM4Di-mCherry). In the optogenetic experiments, AAV5 carrying channelrhodopsin-2 (ChR2) conjugated to eYFP driven by the CaMKIIα promoter (AAV5-CaMKIIα-ChR2-eYFP) was used to selectively express ChR2 onto the PBN neurons. To silence the neurons, AAV5-hSyn-DIO-hM4Di-mCherry was injected into the CeA region. To activate the neurons, the AAV5-hSyn-DIO-hM3Dq-mCherry virus was injected into the CeA region and the AAV5-CaMKIIα-ChR2-eYFP virus was injected into the PBN region. In addition, a viral vector carrying the red fluorescent protein (AAV5-hSyn-DIO-mCherry) was used as the control. In the in vivo calcium imaging experiment, the AAV5-Syn-Flex-GCaMP6s-WPRE-SV40 was injected into the CeA region. All viral vectors were purchased from the Vector Core at the University of North Carolina (Chapel Hill, NC, USA) or Addgene Vector Core (Watertown, MA, USA).</p></sec><sec id="s4-3"><title>Acid-induced MP model</title><p>The model of acid-induced MP (<xref ref-type="bibr" rid="bib47">Sluka et al., 2001</xref>) was used as a preclinical fibromyalgia-like MP model. All mice were briefly anesthetized with isoflurane (4% induction, 1.5–2% maintenance in O<sub>2</sub>; Halocarbon Laboratories, North Augusta, SC, USA). After anesthesia, the MP and Ctrl mice received 20 μL injections of acidic saline (pH 4.0) and neutral saline (pH 7.2), respectively, on day 0 in the left gastrocnemius muscle. After 3 days (day 3), the same gastrocnemius muscle was re-injected with acidic or neutral saline. The pH value of the 2-(<italic>N</italic>-morpholino) ethanesulfonic acid (MES)-buffered saline (154 mM of NaCl, 10 mM of MES) was used to construct both the acidic and neutral saline, while the pH values were adjusted with 0.1 M of HCl or NaOH.</p></sec><sec id="s4-4"><title>Immunohistochemistry</title><p>Mice were deeply anesthetized and PBS (0.9% NaCl in 0.01 M of phosphate buffer, pH 7.4) was sequentially perfused through the left ventricle, followed by 30 mL of ice-cold 4% paraformaldehyde in 0.1 M of PBS. The brain was rapidly removed and fixed in 4% paraformaldehyde in 0.1 M of PBS for 6 hr at 4°C, after which it was cryoprotected with 15% sucrose in 0.1 M of PBS for 24 hr at 4°C, followed by 30% sucrose in 0.1 M of PBS for 24 hr at 4°C. Coronal brain sections (45 μm thickness) containing the amygdala and surrounding regions were cut using a cryostat microtome (CM1900, Leica Microsystems, Nussloch, Germany). Sections were treated with 3% H<sub>2</sub>O<sub>2</sub> for 10 min and then blocked with 0.1% Triton X-100 in TBS containing 2% bovine serum albumin and 2% normal goat serum (Vector Laboratories, Burlingame, CA, USA) for 2 hr at room temperature. To confirm the expression of the virus in the CeA, the slices were stained with a primary antibody: rabbit anti-red fluorescent protein (1:300; Rockland, Limerick, PA, USA) or rabbit anti-PKCδ (1:500; Abcam, Cambridge, UK) or rat anti-SST (1:500; Abcam, Cambridge, UK). After 2 days, the slices were stained with a secondary antibody: goat anti-rabbit Alexa Fluor 594 (1:500; Thermo Fisher Scientific, Waltham, MA, USA) or goat anti-rabbit Alexa Fluor 488 (1:500; Thermo Fisher Scientific, Waltham, MA, USA) or goat anti-rat Alexa Fluor 488 (1:500; Thermo Fisher Scientific, Waltham, MA, USA). The results were examined and imaged under a fluorescence microscope (BX63, Olympus, Tokyo, Japan) or a confocal laser excitation microscope (Leica SP5, Leica Microsystems, Wetzlar, Germany).</p></sec><sec id="s4-5"><title>Stereotaxic surgery</title><p>Mice were deeply anesthetized with isoflurane (4% induction, 1.5–2% maintenance in O<sub>2</sub>; Halocarbon Laboratories, North Augusta, SC, USA) and placed in a stereotaxic injection frame (IVM-3000, Scientifica, Uckfield, UK). The injections were performed using the following stereotaxic coordinates: for the CeA, 1.31 mm posterior from bregma, 2.87 mm lateral from the midline on both sides, and 4.72 mm ventral from the cortical surface; for the PBN, 5.1 mm posterior from bregma, 1.2 mm lateral from the midline on both sides, and 3.2 mm ventral from the cortical surface. During all the surgical procedures, the mice were kept on a heating pad (TCAT-2LV CONTROLLER, Physitemp Instruments, Clifton, NJ, USA or Physiological Biological Temperature Controller TMP-5b, Supertech Instruments, Budapest, Hungary) to maintain their surface body temperatures at 34°C. After securing the head with ear bars, 75% ethanol was used to sterilize the surgical area, and the eyes were protected using an ophthalmic gel. For viral injection, we injected 0.35 and 0.5 μL of the viral solution bilaterally into the CeA and PBN, respectively, using a 10 μL NanoFil syringe and a 34-gauge (G) beveled metal needle (World Precision Instruments, Sarasota, FL, USA). The flow rate (0.1 μL/min) was controlled with a nanopump controller (KD Scientific, Holliston, MA, USA). After viral injection, the needle was raised 0.1 mm above the injection site for an additional 10 min to allow the virus to diffuse before being withdrawn slowly. To reach optimal viral expression, all the animals were allowed to recover for at least 4 weeks before conducting behavioral and electrophysiological experiments.</p></sec><sec id="s4-6"><title>Cannula implantation for intra-CeA drug application</title><p>The cannula for implantation consisted of the guide (27 G, 0.41 mm in diameter and 5 mm long; RWD Life Science, Shenzhen, China) and dummy (0.2 mm in diameter and 5.5 mm long; RWD Life Science, Shenzhen, China) cannulas. The guide cannulas were placed in the CeA bilaterally (±2.87 mm laterally, 1.31 mm posteriorly, 4.65 mm ventrally). To fix the guide cannulas onto the skull, dental resin cement C&amp;B Super-Bond (Sun Medical, Moriyama, Japan) was applied to the surface of the skull around the cannula for approximately 10 min. After the resin cement hardened, the cannula was removed from the homemade holder and the mice were placed back into their home cages for recovery. One week after recovery, the mice underwent behavioral tests. During the test, the dummy cannulas were replaced by internal cannulas (0.21 mm in diameter and 5.5 mm long; RWD Life Science, Shenzhen, China). We bilaterally injected 0.15 μL of ACSF at a rate of 75 nL/min through the cannulas on days 15 and 18. For the delivery of PGB (Pfizer, New York, NY, USA), we bilaterally injected 0.15 μL of 1 mM PGB at a rate of 75 nL/min through the cannulas on days 16 and 19. For the priming experiment, we bilaterally injected 0.15 μL of ACSF or PGB through the cannulas right after the second acidic saline injection on day 3.</p></sec><sec id="s4-7"><title>In vivo calcium imaging</title><p>After injection of the virus, the GRIN lens (diameter, 0.5 mm; length, 6.1 mm; Inscopix, Palo Alto, CA, USA) was placed in the CeA (2.87 mm laterally, 1.31 mm posteriorly, 4.72 mm ventrally) region. To fix the lens onto the skull, dental resin cement C&amp;B Super-Bond (Sun Medical, Moriyama, Japan) was applied to the surface of the skull around the lens for approximately 10 min. After the resin cement hardened, the lens was removed from the holder and the mice were placed back into their home cages for recovery. Three to four weeks after injection of the virus, the mice underwent MP induction. Two weeks after MP induction, the calcium activities of the CeA-SST neurons were recorded. Calcium signals were detected using the miniscope system (nVista 3.0, Inscopix). The blue light-emitting diode (LED) power was approximately 1.4 mW at the focal plane. The images (1280×800 pixels) were acquired at a 15 or 20 Hz frame rate. After adapting the miniscope, the calcium imaging was recorded from freely moving mice in the home cage. The analysis was performed using the Inscopix data processing software (version 1.6.0, Inscopix). The constrained nonnegative matrix factorization was applied to extract calcium event traces (ΔF/F) of all the recorded CeA-SST neurons.</p></sec><sec id="s4-8"><title>Calcium signal analysis</title><p>Before and after the PGB treatment, the frequencies and mean amplitudes of the events were detected using the built-in template searching function (Clampfit 10.3, Molecular Devices, Sunnyvale, CA, USA). For the AUC analysis, in order to eliminate calcium-independent residual noise and to improve the signal-to-noise ratio, the Gaussian kernel filter (<inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mtext> </mml:mtext><mml:mfrac><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mi>K</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mi>K</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mi>K</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mtext> </mml:mtext><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mi>b</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula>) with b (bandwidth) set as 10 frames was applied to the whole calcium trace of single neurons. Subsequently, calcium signals (ΔF/F) before and after the PGB treatment were concatenated and normalized to the range of 0–1 (<inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mtext> </mml:mtext><mml:mfrac><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula>). For both the BL and PGB trials, calcium traces recorded in the initial 6 min were extracted and resampled to 10 Hz by interpolation. Spontaneous activity of a neuron was measured via calibrating its AUC per second from the normalized calcium activity of a given trial. The standard deviation of all neuron changes in the AUC per second following PGB application (<inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) was arbitrarily used as a cutoff threshold to identify PGB-responsive neurons. After application of PGB, those with ΔAUC greater than <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> were arbitrarily defined as either the PGB excitation or inhibition group. The remaining neurons were categorized as the no effect group.</p></sec><sec id="s4-9"><title>Slice preparation and electrophysiology</title><p>After the behavioral tests, AAV-injected mice were sacrificed and acute coronal brain slices of 300 μm thickness were cut using a vibratome (DTK-1000, Dosaka, Kyoto, Japan) in ice-cold sucrose saline containing the following (in mM): 87 NaCl, 25 NaHCO<sub>3</sub>, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 2.5 KCl, 10 glucose, 75 sucrose, 0.5 CaCl<sub>2</sub>, and 7 MgCl<sub>2</sub>. Slices were allowed to recover in an oxygenated (95% O<sub>2</sub> and 5% CO<sub>2</sub>) sucrose saline-containing chamber at 34°C for 30 min before being maintained at room temperature until recording. During the experiment, slices were transferred to a submerged chamber and perfused with oxygenated ACSF containing the following (in mM): 125 NaCl, 25 NaHCO<sub>3</sub>, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 2.5 KCl, 25 glucose, 2 CaCl<sub>2</sub>, and 1 MgCl<sub>2</sub>. The expression of the virus or tdTomato expression was confirmed by red or green fluorescence and the neurons in the CeA were visually selected for recordings under an infrared differential interference contrast microscope (BX51WI, Olympus, Tokyo, Japan) equipped with an LED source (505 and 590 nm, LED4D162, controlled by DC4104 driver, Thorlabs, Newton, NJ, USA). For optical stimulation, ChR2-expressing neurons were excited by 470 nm LED light (driven by DC4104 driver, Thorlabs, Newton, NJ, USA). Whole-cell patch-clamp recordings were conducted using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA). Recording electrodes (3–6 MΩ) were pulled from borosilicate glass capillaries (outer diameter, 1.5 mm; 0.32 mm wall thickness; Harvard Apparatus). The glass microelectrodes were filled with a low Cl<sup>-</sup> internal solution containing the following (in mM): 136.8 K-gluconate, 7.2 KCl, 0.2 EGTA, 4 MgATP, 10 HEPES, 7 NA<sub>2</sub>-phosphocreatine, 0.5 Na<sub>3</sub>GTP, and 0.4% biocytin (wt/vol; ~310 mOsm/L). The pipette capacitance was compensated. Signals were low-pass filtered at 5 kHz and sampled at 10 kHz using a digitizer (Digidata 1440 A; Molecular Devices, Sunnyvale, CA, USA). In the ex vivo slice recordings, the following antagonists were added to the ACSF: SR-95531 (1 µM; Abcam), CGP-55845 (1 µM; Tocris), and kynurenic acid (2 mM; MERCK) to block the GABA<sub>A</sub>, GABA<sub>B</sub>, AMPA/NMDA receptors, respectively. Tetrodotoxin (TTX; 1 µM; Tocris) was applied to block sodium channels in the experiments of the mEPSC recording. CNO (5 µM; MERCK) was used to activate the DREADDs. PGB (500 µM; Pfizer, New York, NY, USA) was used to examine its potential effects on synaptic transmission at the PBN to the CeA-SST or CeA-PKCδ neuron synapses.</p></sec><sec id="s4-10"><title>Behavioral tests</title><p>Mice were handled for at least 3 days before the behavioral tests (<xref ref-type="bibr" rid="bib29">Hurst and West, 2010</xref>). All the behavioral tests were conducted during the light period of the light-dark cycle. Mice were moved to the behavioral room with dim light at least 30 min before performing the experiments. In chemogenetic experiments, CNO was freshly dissolved in injection saline (10% v/v DMSO in 0.9% NaCl) and i.p. injected at 5 mg/kg of body weight. Behavioral tests were performed approximately 50 min following CNO injection.</p><sec id="s4-10-1"><title>Von Frey filament test</title><p>Mechanical hypersensitivity was assessed using the von Frey filament test. A series of von Frey filaments of increasing stiffness (0.04–1.4 g) were applied to the plantar surface of both the hindpaws. Each filament was applied five times and the lowest force that caused at least three withdrawals out of the five stimuli was considered the threshold (g) (<xref ref-type="bibr" rid="bib5">Blackburn-Munro and Jensen, 2003</xref>; <xref ref-type="bibr" rid="bib22">Hao et al., 1999</xref>).</p></sec><sec id="s4-10-2"><title>Marble burying test</title><p>The clean cage (height, 12.5 cm; length, 28 cm; width, 17 cm) was filled approximately 6 cm high with bedding. Twenty-four glass marbles (approximately 1.5 cm in diameter) were evenly spaced on the top of the bedding with an approximately 3 cm distance between each pair of marbles. Mice were placed individually into the cages and left undisturbed for 30 min (<xref ref-type="bibr" rid="bib10">Chang et al., 2017</xref>). Marbles were considered buried if at least two-thirds of their surface was covered by bedding.</p></sec><sec id="s4-10-3"><title>L/D box test</title><p>The test apparatus consisted of a two-compartment light-dark box (height, 40 cm; length, 42 cm; width, 42 cm) connected by a central opening at the floor level. Mice were placed individually in the center of the brightly lit side of the box and left undisturbed for 10 min of exploration. Transitions between the two compartments and total locomotor activity were recorded using the Tru-scan 2.0 system (Coulbourn Instrument, Allentown, PA, USA).</p></sec><sec id="s4-10-4"><title>EPM</title><p>The EPM is a common anxiety test that produces approach avoidance conflict (<xref ref-type="bibr" rid="bib53">Walf and Frye, 2007</xref>). The EPM apparatus consisted of two open arms (length, 30 cm; width, 5 cm) and two closed arms (length, 30 cm; width, 5 cm; height, 25 cm) extending from the intersection zone (5 cm × 5 cm). The EPM was elevated 50 cm from the floor. The recording camera was placed above the maze. Mice were placed in the center of the intersection zone and then allowed to freely explore for 10 min. The open-arm time and total travel distance were measured using the video tracking software EthoVision XT 13 (Noldus Information Technology, Leesburg, VA, USA).</p></sec><sec id="s4-10-5"><title>Sociability test</title><p>The three-chamber sociability test has been successfully employed to study social affiliation in several mouse lines (<xref ref-type="bibr" rid="bib56">Yang et al., 2011</xref>). The social approach apparatus was an open-topped plastic box (height, 22 cm; length, 52.5 cm; width, 42.5 cm) divided into three chambers by two clear walls. The center compartment (length, 16.5 cm) was smaller than the other two compartments, which were equal in size to each other (length, 18 cm). The dividing walls had retractable doorways, allowing access into each chamber. A wire cup (bottom diameter, 5  cm) was used to confine the novel mice. Mice were housed alone for 24 hr before the test and underwent the test in a darkened room. The lighting in the two side chambers was maintained at approximately 5–6 lux calibrated by a hand-held lux meter. Mice were habituated to the inverted wire cup for two 15 min sessions before the test session. Test mice were confined in the center chamber at the beginning of each phase for 10 min for habituation. During the habituation phase, each of the two side chambers contained an inverted empty wire cup. To initiate each 10 min phase, the doorways to the side chambers were opened, and the mice were allowed to explore freely. During the sociability phase, an unfamiliar mouse was enclosed in one of the wire cups in the side chambers. The time spent in each chamber and time spent exploring the enclosed novel mice or empty cups were recorded with a camera mounted overhead and analyzed using the EthoVision XT software 13 (Noldus Information Technology, Leesburg, VA, USA).</p></sec><sec id="s4-10-6"><title>FST</title><p>The FST consisted of a transparent acrylic cylindrical container (height, 25 cm; width, 10 cm) filled with water to a height of 16 cm (<xref ref-type="bibr" rid="bib8">Can et al., 2012</xref>; <xref ref-type="bibr" rid="bib9">Castagné et al., 2010</xref>; <xref ref-type="bibr" rid="bib46">Slattery and Cryan, 2012</xref>). The mouse was placed in the water maintained at 20–22°C for 6 min. We measured the immobility time that was indicative of depression using the video tracking software EthoVision XT 13 (Noldus Information Technology, Leesburg, VA, USA).</p></sec></sec><sec id="s4-11"><title>Data analysis and statistics</title><p>Data were analyzed using Clampfit 10.3 (Molecular Devices, Sunnyvale, CA, USA), MiniAnalysis (Synaptosoft, Inc, Fort Lee, NJ, USA), GraphPad Prism 6 (GraphPad Software, Inc, San Diego, CA, USA) and a custom-made program written in Python. To define the effect of PGB, we classified PGB-inhibited neurons as having the EPSC inhibition &gt;×1 SD<sub>BL</sub>. Statistical significance was tested using the two-way analysis of variance (ANOVA) with the Tukey’s post hoc test, two-way ANOVA with the Bonferroni’s multiple comparison test, Kolmogorov–Smirnov test, Wilcoxon matched-pairs signed rank test, or Mann–Whitney test at the significance level (p) indicated. Data are presented as mean ± standard error of mean (SEM). Significance levels were set at p&lt;0.05 (*), p&lt;0.01 (**), p&lt;0.001 (***), or p&lt;0.0001 (****).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis</p></fn><fn fn-type="con" id="con5"><p>Conceptualization</p></fn><fn fn-type="con" id="con6"><p>Conceptualization</p></fn><fn fn-type="con" id="con7"><p>Conceptualization</p></fn><fn fn-type="con" id="con8"><p>Conceptualization</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Funding acquisition, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The animals were handled in accordance with national and institutional guidelines. All behavioral procedures were conducted in accordance with the protocol (No. 1080317) approved by the Institutional Animal Care and Use Committee (IACUC) of the National Yang Ming Chiao Tung University.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-78610-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-78610-transrepform1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Source data for all figures have been provided.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr SC Lin, Dr PH Chiang (National Yang Ming Chiao Tung University, Taiwan), Dr A Dominique (University of Liege, Belgium), and Dr P Turko (Charite University Medicine Berlin, Germany) for commenting on earlier versions of the manuscript and all the members of the Lien lab for their insightful discussions. We also thank Pfizer for the supply of pregabalin. Funding: This work was financially supported by the Brain Research Center, National Yang Ming Chiao Tung University from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan, National Health Research Institutes (NHRI-EX111-11135NI), and Ministry of Science and Technology (MOST 108–2320-B-010-026-MY3, MOST 109–2926-I-010–506, MOST 110–2321-B-010-006, MOST 111-2321-B-A49-005) in Taiwan.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahrens</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>MV</given-names></name><name><surname>Furlan</surname><given-names>A</given-names></name><name><surname>Hwang</surname><given-names>GR</given-names></name><name><surname>Paik</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Penzo</surname><given-names>MA</given-names></name><name><surname>Tollkuhn</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A central extended amygdala circuit that modulates anxiety</article-title><source>The Journal of Neuroscience</source><volume>38</volume><fpage>5567</fpage><lpage>5583</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0705-18.2018</pub-id><pub-id pub-id-type="pmid">29844022</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allsop</surname><given-names>SA</given-names></name><name><surname>Vander Weele</surname><given-names>CM</given-names></name><name><surname>Wichmann</surname><given-names>R</given-names></name><name><surname>Tye</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Optogenetic insights on the relationship between anxiety-related behaviors and social deficits</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>8</volume><elocation-id>241</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2014.00241</pub-id><pub-id pub-id-type="pmid">25076878</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babaev</surname><given-names>O</given-names></name><name><surname>Piletti Chatain</surname><given-names>C</given-names></name><name><surname>Krueger-Burg</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inhibition in the amygdala anxiety circuitry</article-title><source>Experimental &amp; Molecular Medicine</source><volume>50</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1038/s12276-018-0063-8</pub-id><pub-id pub-id-type="pmid">29628509</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>DL</given-names></name><name><surname>Clark</surname><given-names>AJ</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name><name><surname>Dib-Hajj</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The role of voltage-gated sodium channels in pain signaling</article-title><source>Physiological Reviews</source><volume>99</volume><fpage>1079</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1152/physrev.00052.2017</pub-id><pub-id pub-id-type="pmid">30672368</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackburn-Munro</surname><given-names>G</given-names></name><name><surname>Jensen</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain</article-title><source>European Journal of Pharmacology</source><volume>460</volume><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/s0014-2999(02)02924-2</pub-id><pub-id pub-id-type="pmid">12559370</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bliss</surname><given-names>TVP</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name><name><surname>Morris</surname><given-names>RGM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Synaptic plasticity in health and disease: introduction and overview</article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>369</volume><elocation-id>20130129</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2013.0129</pub-id><pub-id pub-id-type="pmid">24298133</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calhoon</surname><given-names>GG</given-names></name><name><surname>Tye</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Resolving the neural circuits of anxiety</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>1394</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1038/nn.4101</pub-id><pub-id pub-id-type="pmid">26404714</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Can</surname><given-names>A</given-names></name><name><surname>Dao</surname><given-names>DT</given-names></name><name><surname>Arad</surname><given-names>M</given-names></name><name><surname>Terrillion</surname><given-names>CE</given-names></name><name><surname>Piantadosi</surname><given-names>SC</given-names></name><name><surname>Gould</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The mouse forced swim test</article-title><source>Journal of Visualized Experiments</source><volume>59</volume><elocation-id>e3638</elocation-id><pub-id pub-id-type="doi">10.3791/3638</pub-id><pub-id pub-id-type="pmid">22314943</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castagné</surname><given-names>V</given-names></name><name><surname>Moser</surname><given-names>P</given-names></name><name><surname>Roux</surname><given-names>S</given-names></name><name><surname>Porsolt</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice</article-title><source>Current Protocols in Pharmacology</source><volume>Chapter 5</volume><elocation-id>Unit</elocation-id><pub-id pub-id-type="doi">10.1002/0471141755.ph0508s49</pub-id><pub-id pub-id-type="pmid">22294373</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Cole</surname><given-names>TB</given-names></name><name><surname>Costa</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Behavioral phenotyping for autism spectrum disorders in mice</article-title><source>Current Protocols in Toxicology</source><volume>72</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1002/cptx.19</pub-id><pub-id pub-id-type="pmid">28463420</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WK</given-names></name><name><surname>Liu</surname><given-names>IY</given-names></name><name><surname>Chang</surname><given-names>YT</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Yen</surname><given-names>CT</given-names></name><name><surname>Shin</surname><given-names>HS</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ca (V) 3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>10360</fpage><lpage>10368</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1041-10.2010</pub-id><pub-id pub-id-type="pmid">20685979</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WN</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Lin</surname><given-names>SH</given-names></name><name><surname>Wong</surname><given-names>CW</given-names></name><name><surname>Sun</surname><given-names>WH</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Roles of ASIC3, TRPV1, and nav1.8 in the transition from acute to chronic pain in a mouse model of fibromyalgia</article-title><source>Molecular Pain</source><volume>10</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/1744-8069-10-40</pub-id><pub-id pub-id-type="pmid">24957987</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WH</given-names></name><name><surname>Lien</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Neuronal basis for pain-like and anxiety-like behaviors in the central nucleus of the amygdala</article-title><source>Pain</source><volume>163</volume><fpage>e463</fpage><lpage>e475</lpage><pub-id pub-id-type="doi">10.1097/j.pain.0000000000002389</pub-id><pub-id pub-id-type="pmid">34174041</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Yang</surname><given-names>HW</given-names></name><name><surname>Chang</surname><given-names>YT</given-names></name><name><surname>Bai</surname><given-names>SW</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Yen</surname><given-names>CT</given-names></name><name><surname>Min</surname><given-names>MY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Role of extracellular signal-regulated kinase in synaptic transmission and plasticity of a nociceptive input on capsular central amygdaloid neurons in normal and acid-induced muscle pain mice</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>2258</fpage><lpage>2270</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5564-10.2011</pub-id><pub-id pub-id-type="pmid">21307262</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciocchi</surname><given-names>S</given-names></name><name><surname>Herry</surname><given-names>C</given-names></name><name><surname>Grenier</surname><given-names>F</given-names></name><name><surname>Wolff</surname><given-names>SBE</given-names></name><name><surname>Letzkus</surname><given-names>JJ</given-names></name><name><surname>Vlachos</surname><given-names>I</given-names></name><name><surname>Ehrlich</surname><given-names>I</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Stadler</surname><given-names>MB</given-names></name><name><surname>Müller</surname><given-names>C</given-names></name><name><surname>Lüthi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Encoding of conditioned fear in central amygdala inhibitory circuits</article-title><source>Nature</source><volume>468</volume><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1038/nature09559</pub-id><pub-id pub-id-type="pmid">21068837</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clauw</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fibromyalgia: a clinical review</article-title><source>JAMA</source><volume>311</volume><fpage>1547</fpage><lpage>1555</lpage><pub-id pub-id-type="doi">10.1001/jama.2014.3266</pub-id><pub-id pub-id-type="pmid">24737367</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>RL</given-names></name><name><surname>Lechner</surname><given-names>SM</given-names></name><name><surname>Williams</surname><given-names>ME</given-names></name><name><surname>Prodanovich</surname><given-names>P</given-names></name><name><surname>Bleicher</surname><given-names>L</given-names></name><name><surname>Varney</surname><given-names>MA</given-names></name><name><surname>Gu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Differential distribution of voltage-gated calcium channel alpha-2 delta (alpha2delta) subunit mrna-containing cells in the rat central nervous system and the dorsal root ganglia</article-title><source>The Journal of Comparative Neurology</source><volume>491</volume><fpage>246</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1002/cne.20693</pub-id><pub-id pub-id-type="pmid">16134135</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Saal</surname><given-names>D</given-names></name><name><surname>Marie</surname><given-names>H</given-names></name><name><surname>Neve</surname><given-names>R</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Creb modulates excitability of nucleus accumbens neurons</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>475</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1038/nn1661</pub-id><pub-id pub-id-type="pmid">16520736</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duvarci</surname><given-names>S</given-names></name><name><surname>Pare</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Amygdala microcircuits controlling learned fear</article-title><source>Neuron</source><volume>82</volume><fpage>966</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.04.042</pub-id><pub-id pub-id-type="pmid">24908482</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadok</surname><given-names>JP</given-names></name><name><surname>Markovic</surname><given-names>M</given-names></name><name><surname>Tovote</surname><given-names>P</given-names></name><name><surname>Lüthi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>New perspectives on central amygdala function</article-title><source>Current Opinion in Neurobiology</source><volume>49</volume><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.02.009</pub-id><pub-id pub-id-type="pmid">29522976</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Ishola</surname><given-names>T</given-names></name><name><surname>Scerbo</surname><given-names>M</given-names></name><name><surname>Adwanikar</surname><given-names>H</given-names></name><name><surname>Ramsey</surname><given-names>C</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior</article-title><source>Molecular Pain</source><volume>4</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1186/1744-8069-4-26</pub-id><pub-id pub-id-type="pmid">18631385</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>JX</given-names></name><name><surname>Xu</surname><given-names>IS</given-names></name><name><surname>Xu</surname><given-names>XJ</given-names></name><name><surname>Wiesenfeld-Hallin</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Effects of intrathecal morphine, clonidine and baclofen on allodynia after partial sciatic nerve injury in the rat</article-title><source>Acta Anaesthesiologica Scandinavica</source><volume>43</volume><fpage>1027</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1034/j.1399-6576.1999.431010.x</pub-id><pub-id pub-id-type="pmid">10593466</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haubensak</surname><given-names>W</given-names></name><name><surname>Kunwar</surname><given-names>PS</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Ciocchi</surname><given-names>S</given-names></name><name><surname>Wall</surname><given-names>NR</given-names></name><name><surname>Ponnusamy</surname><given-names>R</given-names></name><name><surname>Biag</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>HW</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Callaway</surname><given-names>EM</given-names></name><name><surname>Fanselow</surname><given-names>MS</given-names></name><name><surname>Lüthi</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genetic dissection of an amygdala microcircuit that gates conditioned fear</article-title><source>Nature</source><volume>468</volume><fpage>270</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1038/nature09553</pub-id><pub-id pub-id-type="pmid">21068836</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Häuser</surname><given-names>W</given-names></name><name><surname>Bernardy</surname><given-names>K</given-names></name><name><surname>Uçeyler</surname><given-names>N</given-names></name><name><surname>Sommer</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials</article-title><source>Pain</source><volume>145</volume><fpage>69</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2009.05.014</pub-id><pub-id pub-id-type="pmid">19539427</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooten</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Chronic pain and mental health disorders: shared neural mechanisms, epidemiology, and treatment</article-title><source>Mayo Clinic Proceedings</source><volume>91</volume><fpage>955</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1016/j.mayocp.2016.04.029</pub-id><pub-id pub-id-type="pmid">27344405</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>WH</given-names></name><name><surname>Kuo</surname><given-names>N</given-names></name><name><surname>Fang</surname><given-names>GW</given-names></name><name><surname>Huang</surname><given-names>HS</given-names></name><name><surname>Wu</surname><given-names>KP</given-names></name><name><surname>Zimmer</surname><given-names>A</given-names></name><name><surname>Cheng</surname><given-names>JK</given-names></name><name><surname>Lien</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Wiring specificity and synaptic diversity in the mouse lateral central amygdala</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>4549</fpage><lpage>4563</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3309-15.2016</pub-id><pub-id pub-id-type="pmid">27098697</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>H-J</given-names></name><name><surname>Gereau</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. II. modulation of neuronal excitability</article-title><source>Journal of Neurophysiology</source><volume>90</volume><fpage>1680</fpage><lpage>1688</lpage><pub-id pub-id-type="doi">10.1152/jn.00341.2003</pub-id><pub-id pub-id-type="pmid">12750418</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>D</given-names></name><name><surname>Sakurai</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>BX</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>General anesthetics activate a potent central pain-suppression circuit in the amygdala</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>854</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-0632-8</pub-id><pub-id pub-id-type="pmid">32424286</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurst</surname><given-names>JL</given-names></name><name><surname>West</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Taming anxiety in laboratory mice</article-title><source>Nature Methods</source><volume>7</volume><fpage>825</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1500</pub-id><pub-id pub-id-type="pmid">20835246</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>R</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain</article-title><source>Pain</source><volume>127</volume><fpage>161</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2006.09.003</pub-id><pub-id pub-id-type="pmid">17055162</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyengar</surname><given-names>S</given-names></name><name><surname>Ossipov</surname><given-names>MH</given-names></name><name><surname>Johnson</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine</article-title><source>Pain</source><volume>158</volume><fpage>543</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1097/j.pain.0000000000000831</pub-id><pub-id pub-id-type="pmid">28301400</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kandasamy</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><chapter-title>The pharmacology of nociceptor priming</chapter-title><person-group person-group-type="editor"><name><surname>Kandasamy</surname><given-names>R</given-names></name></person-group><source>Handbook of Experimental Pharmacology</source><publisher-name>Elesiver</publisher-name><fpage>15</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/978-3-662-46450-2_2</pub-id><pub-id pub-id-type="pmid">25846612</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolch</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions</article-title><source>The Biochemical Journal</source><volume>351 Pt 2</volume><fpage>289</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">11023813</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuner</surname><given-names>R</given-names></name><name><surname>Flor</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural plasticity and reorganisation in chronic pain</article-title><source>Nature Reviews. Neuroscience</source><volume>18</volume><fpage>20</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/nrn.2016.162</pub-id><pub-id pub-id-type="pmid">27974843</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuner</surname><given-names>R</given-names></name><name><surname>Kuner</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cellular circuits in the brain and their modulation in acute and chronic pain</article-title><source>Physiological Reviews</source><volume>101</volume><fpage>213</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1152/physrev.00040.2019</pub-id><pub-id pub-id-type="pmid">32525759</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeDoux</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Emotion circuits in the brain</article-title><source>Annual Review of Neuroscience</source><volume>23</volume><fpage>155</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.23.1.155</pub-id><pub-id pub-id-type="pmid">10845062</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Penzo</surname><given-names>MA</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Kopec</surname><given-names>CD</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Experience-dependent modification of a central amygdala fear circuit</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>332</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1038/nn.3322</pub-id><pub-id pub-id-type="pmid">23354330</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JN</given-names></name><name><surname>Sheets</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Spared nerve injury differentially alters parabrachial monosynaptic excitatory inputs to molecularly specific neurons in distinct subregions of the central amygdala</article-title><source>Pain</source><volume>161</volume><fpage>166</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1097/j.pain.0000000000001691</pub-id><pub-id pub-id-type="pmid">31479066</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>SH</given-names></name><name><surname>Zhao</surname><given-names>WJ</given-names></name><name><surname>Yin</surname><given-names>JB</given-names></name><name><surname>Chen</surname><given-names>YB</given-names></name><name><surname>Li</surname><given-names>JN</given-names></name><name><surname>Feng</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>YC</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>YL</given-names></name><name><surname>Li</surname><given-names>YQ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A neural circuit from thalamic paraventricular nucleus to central amygdala for the facilitation of neuropathic pain</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>7837</fpage><lpage>7854</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2487-19.2020</pub-id><pub-id pub-id-type="pmid">32958568</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>SEE</given-names></name><name><surname>Nicolson</surname><given-names>KP</given-names></name><name><surname>Smith</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Chronic pain: a review of its epidemiology and associated factors in population-based studies</article-title><source>British Journal of Anaesthesia</source><volume>123</volume><fpage>e273</fpage><lpage>e283</lpage><pub-id pub-id-type="doi">10.1016/j.bja.2019.03.023</pub-id><pub-id pub-id-type="pmid">31079836</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>MY</given-names></name><name><surname>Yang</surname><given-names>HW</given-names></name><name><surname>Yen</surname><given-names>CT</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Cheng</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ERK, synaptic plasticity and acid-induced muscle pain</article-title><source>Communicative &amp; Integrative Biology</source><volume>4</volume><fpage>394</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.4161/cib.4.4.15694</pub-id><pub-id pub-id-type="pmid">21966555</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neugebauer</surname><given-names>V</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Bird</surname><given-names>GC</given-names></name><name><surname>Han</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The amygdala and persistent pain</article-title><source>The Neuroscientist</source><volume>10</volume><fpage>221</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1177/1073858403261077</pub-id><pub-id pub-id-type="pmid">15155061</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penzo</surname><given-names>MA</given-names></name><name><surname>Robert</surname><given-names>V</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fear conditioning potentiates synaptic transmission onto long-range projection neurons in the lateral subdivision of central amygdala</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>2432</fpage><lpage>2437</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4166-13.2014</pub-id><pub-id pub-id-type="pmid">24523533</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penzo</surname><given-names>MA</given-names></name><name><surname>Robert</surname><given-names>V</given-names></name><name><surname>Tucciarone</surname><given-names>J</given-names></name><name><surname>De Bundel</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Van Aelst</surname><given-names>L</given-names></name><name><surname>Darvas</surname><given-names>M</given-names></name><name><surname>Parada</surname><given-names>LF</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The paraventricular thalamus controls a central amygdala fear circuit</article-title><source>Nature</source><volume>519</volume><fpage>455</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1038/nature13978</pub-id><pub-id pub-id-type="pmid">25600269</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichling</surname><given-names>DB</given-names></name><name><surname>Levine</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Critical role of nociceptor plasticity in chronic pain</article-title><source>Trends in Neurosciences</source><volume>32</volume><fpage>611</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2009.07.007</pub-id><pub-id pub-id-type="pmid">19781793</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slattery</surname><given-names>DA</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Using the rat forced swim test to assess antidepressant-like activity in rodents</article-title><source>Nature Protocols</source><volume>7</volume><fpage>1009</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.044</pub-id><pub-id pub-id-type="pmid">22555240</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sluka</surname><given-names>KA</given-names></name><name><surname>Kalra</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia</article-title><source>Muscle &amp; Nerve</source><volume>24</volume><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1002/1097-4598(200101)24:1&lt;37::aid-mus4&gt;3.0.co;2-8</pub-id><pub-id pub-id-type="pmid">11150964</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sluka</surname><given-names>KA</given-names></name><name><surname>Clauw</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neurobiology of fibromyalgia and chronic widespread pain</article-title><source>Neuroscience</source><volume>338</volume><fpage>114</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.06.006</pub-id><pub-id pub-id-type="pmid">27291641</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevans</surname><given-names>JM</given-names></name><name><surname>Delitto</surname><given-names>A</given-names></name><name><surname>Khoja</surname><given-names>SS</given-names></name><name><surname>Patterson</surname><given-names>CG</given-names></name><name><surname>Smith</surname><given-names>CN</given-names></name><name><surname>Schneider</surname><given-names>MJ</given-names></name><name><surname>Freburger</surname><given-names>JK</given-names></name><name><surname>Greco</surname><given-names>CM</given-names></name><name><surname>Freel</surname><given-names>JA</given-names></name><name><surname>Sowa</surname><given-names>GA</given-names></name><name><surname>Wasan</surname><given-names>AD</given-names></name><name><surname>Brennan</surname><given-names>GP</given-names></name><name><surname>Hunter</surname><given-names>SJ</given-names></name><name><surname>Minick</surname><given-names>KI</given-names></name><name><surname>Wegener</surname><given-names>ST</given-names></name><name><surname>Ephraim</surname><given-names>PL</given-names></name><name><surname>Friedman</surname><given-names>M</given-names></name><name><surname>Beneciuk</surname><given-names>JM</given-names></name><name><surname>George</surname><given-names>SZ</given-names></name><name><surname>Saper</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Risk factors associated with transition from acute to chronic low back pain in US patients seeking primary care</article-title><source>JAMA Network Open</source><volume>4</volume><elocation-id>e2037371</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.37371</pub-id><pub-id pub-id-type="pmid">33591367</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>WH</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Roles of proton-sensing receptors in the transition from acute to chronic pain</article-title><source>Journal of Dental Research</source><volume>95</volume><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1177/0022034515618382</pub-id><pub-id pub-id-type="pmid">26597969</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>JM</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Amygdala plasticity and pain</article-title><source>Pain Research &amp; Management</source><volume>2017</volume><elocation-id>8296501</elocation-id><pub-id pub-id-type="doi">10.1155/2017/8296501</pub-id><pub-id pub-id-type="pmid">29302197</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velly</surname><given-names>AM</given-names></name><name><surname>Mohit</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Epidemiology of pain and relation to psychiatric disorders</article-title><source>Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry</source><volume>87</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.05.012</pub-id><pub-id pub-id-type="pmid">28522289</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walf</surname><given-names>AA</given-names></name><name><surname>Frye</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The use of the elevated plus maze as an assay of anxiety-related behavior in rodents</article-title><source>Nature Protocols</source><volume>2</volume><fpage>322</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.44</pub-id><pub-id pub-id-type="pmid">17406592</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>TD</given-names></name><name><surname>Valdivia</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Ahn</surname><given-names>HS</given-names></name><name><surname>Adke</surname><given-names>AP</given-names></name><name><surname>Martinez Gonzalez</surname><given-names>S</given-names></name><name><surname>Sugimura</surname><given-names>YK</given-names></name><name><surname>Carrasquillo</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dual and opposing functions of the central amygdala in the modulation of pain</article-title><source>Cell Reports</source><volume>29</volume><fpage>332</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.09.011</pub-id><pub-id pub-id-type="pmid">31597095</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Central sensitization: implications for the diagnosis and treatment of pain</article-title><source>Pain</source><volume>152</volume><fpage>S2</fpage><lpage>S15</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2010.09.030</pub-id><pub-id pub-id-type="pmid">20961685</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Silverman</surname><given-names>JL</given-names></name><name><surname>Crawley</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Automated three-chambered social approach task for mice</article-title><source>Current Protocols in Neuroscience</source><volume>Chapter 8</volume><elocation-id>Unit</elocation-id><pub-id pub-id-type="doi">10.1002/0471142301.ns0826s56</pub-id><pub-id pub-id-type="pmid">21732314</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><name><surname>Audette</surname><given-names>KM</given-names></name><name><surname>Sluka</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats</article-title><source>The Journal of Pain</source><volume>8</volume><fpage>422</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2006.11.007</pub-id><pub-id pub-id-type="pmid">17293165</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Won</surname><given-names>J</given-names></name><name><surname>Karlsson</surname><given-names>MG</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Rogerson</surname><given-names>T</given-names></name><name><surname>Balaji</surname><given-names>J</given-names></name><name><surname>Neve</surname><given-names>R</given-names></name><name><surname>Poirazi</surname><given-names>P</given-names></name><name><surname>Silva</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Creb regulates excitability and the allocation of memory to subsets of neurons in the amygdala</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>1438</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1038/nn.2405</pub-id><pub-id pub-id-type="pmid">19783993</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>T</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Luo</surname><given-names>MH</given-names></name><name><surname>Tao</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>BS</given-names></name><name><surname>Zhou</surname><given-names>JN</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Richter-Levin</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A neural circuit for comorbid depressive symptoms in chronic pain</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>1649</fpage><lpage>1658</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0468-2</pub-id><pub-id pub-id-type="pmid">31451801</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78610.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Capogna</surname><given-names>Marco</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01aj84f44</institution-id><institution>University of Aarhus</institution></institution-wrap><country>Denmark</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.03.22.485320" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.22.485320"/></front-stub><body><p>This study investigates the role of the central amygdala (CeA) on the mechanisms underlying chronic pain. An acid-induced muscle pain (AIMP) mouse model is used. Changes of excitatory synaptic and intrinsic excitability of GABAergic somatostatin-expressing (SST+) neurons of the CeA are detected in the chronic MP model. The manuscript is extensive, well-illustrated and contains valuable findings that are likely to inspire future work to progress the understanding of the GABAergic system on patho-physiological events.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78610.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Capogna</surname><given-names>Marco</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01aj84f44</institution-id><institution>University of Aarhus</institution></institution-wrap><country>Denmark</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Capogna</surname><given-names>Marco</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01aj84f44</institution-id><institution>University of Aarhus</institution></institution-wrap><country>Denmark</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.22.485320">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.03.22.485320v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Cellular Mechanisms Underlying Central Sensitization in a Mouse Model of Chronic Muscle Pain&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Marco Capogna as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Gary Westbrook as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>The reviewers and editors agreed that this manuscript is interesting, but they also raised criticism that needs to be taken into consideration. We would like to ask you to prepare a revised version of the manuscript and re-submit. The ideal deadline for re-submission for <italic>eLife</italic> is two months, but some more experiments will be required. Thus the authors should take the time required to address the issues below in a convincing manner as well as respond to the comments of the original reviews.</p><p>1) The investigation of the direct monosynaptic excitatory input from the PBN to CeA neurons should be completed by recordings from PKCd+ neurons. Furthermore, more statistical analyses of the data already submitted should be performed, as explained by Reviewer 1.</p><p>2) Increase the number of animals used with chronic muscle pain treated with PGB for the EPM and sociability behavioral tests.</p><p>3) Provide control data on post-hoc images of the virus injection/expression and co-localization with cell type specific markers; refer to previously published data or publicly available data (Allen Inst) on a2d VGCC subunit expression in parabrachial -CeA.</p><p>4) Better discuss: acute PGB effect on the mechano-sensitivity versus emotional behavior; mechanisms involved in changes in intrinsic excitability of neurons in the MP model; pre- versus pot-synaptic changes detected in the MP model; the source(s) of the spontaneous synaptic events.<italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1) The direct monosynaptic excitatory input from the parabrachial nucleus (PBN), which is enriched with the calcium channel α2δ subunit, onto CeA neurons, is directly investigated by presynaptic optogenetic stimulation and postsynaptic recordings of SST neurons (Figure 5B). I think this is an important approach that should be further exploited. From the data submitted, it seems that such evoked EPSCs are about 3 times bigger in MP mice compared to controls. Provided that optogenetically-evoked EPSCs from control and MP mice could be appropriately compared, e.g. through normalization, is this difference statistically significant?</p><p>It would be also useful to statistically compare the inhibition of the evoked EPSCs by PGB in the two genotypes. Finally, could the Authors perform some more experiments and report the results of a similar experiment by recording from PKCδ neurons, and statistically compare it to the evoked EPSCs recorded in SST neurons?</p><p>2) What mechanisms the Authors envisage to account for by the changes in intrinsic excitability in SST+ and PKCδ neurons observed in MP mice? This aspect should be discussed.</p><p>3) The Authors reported effects on amplitude and/or frequency of sEPSCs and mEPSCs onto CeA recorded neurons seem to suggest a presynaptic mechanism of action. In contrast, the effect of PGB on calcium transient revealed by 1P deep calcium imaging may be interpreted as pre and/or postsynaptic.</p><p>The Authors should make a more definitive conclusion whether they think their data suggest a presynaptic only or also a postsynaptic mechanism of action. It may be difficult to draw any conclusion from sEPSCs since these events are probably due to the release of multiple synaptic vesicles (e.g., mean amplitude of sEPSCs is bigger than the mean amplitude of mEPSCs).</p><p>4) The Authors should discuss the possible source(s) of the spontaneous synaptic events. Do they only originate from PBN terminals or also from BLA principal neurons or elsewhere? Is an analysis of mEPSCs kinetics compatible with an homogeneous pool of presynaptic terminals as source of the m/sEPSCs or rather SST+ and PKCδ+ neurons are biophysically too compact to make out the presence of heterogeneous excitatory inputs perhaps impinging on different spatial domains of the neurons' dendritic trees?</p><p>5) The paw withdraw effect could be replicated by either reducing the CeA SST+ cell activity or by elevating PKCd+ cell activity, but this is not the case for the anxiety-like affective behaviors (Figure 4, Figure 4 S2). Therefore, the PGB effect on the increased paw withdraw threshold and emotion behaviors in the MP mouse model may be caused by distinct circuit mechanisms occurring simultaneously.</p><p>To further elucidate their observation, the Author should test the acute PGB effect on the mechano-sensitivity and emotional behavior separately using a wild type mice or should at least acknowledge this possibility in the discussion.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>My specific issues are outlined below:</p><p>1) Why does the number of animals tested in the different behavioural paradigms (relative to Figures 2 and 4) vary from test to test? Were these different cohorts for each behavioural test?</p><p>2) The size of the cohorts in which PGB was tested (and the relative controls) after induction of chronic muscle pain (Figure 2A-E) is suboptimal for the EPM and sociability tests, also in view of the known relatively high interindividual variability, and should, therefore, be increased.</p><p>3) It should be made more clear in the text that in vivo ca<sup>2+</sup> imaging experiments were performed in mice with chronic muscle pain. Why did the authors did not test the effect of PGB on SST+ neuron activity in control animals? This would have strengthened their findings. Moreover, they could have better exploited their study by testing the effect of PGB on SST+ neuron activity during a von Frey filament stimulation, as this test offers good behavioral bouts in which to analyse ca<sup>2+</sup> transients.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>I have the following comments, which require more experiments to address in order to make the manuscript more convincing.</p><p>1, Figure 3 shows recording results from CeA-SST and CeA-PKCd neurons in the MP mice. Since these neurons at baseline consist of different firing phenotypes (spontaneous, late-firing, and regular firing), it would be useful to know whether all firing types show the same changes in synaptic transmission and excitability in the MP model.</p><p>Notably, in Wilson et al., 2019 paper, they found that CeA neurons require at least 50-80 pA current injection to induce the spikes, whereas in this manuscript, CeA neurons require a much lower current injection to fire. Could the author provide some explanation to this difference?</p><p>2, The number of animals in each test is quite different. For instance, in Figure 4E, n=10 for the mCherry group and n=52 for the hM4Di group; this is a big difference to compare 2 groups. Also, in Figure 4 supplement 2, in the CeA-PKCd experiment, n=4 for the mCherry group and n=13 for the hM3q group. These numbers are significantly fewer than those for CeA-SST hM4Di group (n=52). Please explain how the numbers of animals were assigned to each test? Did the author exclude some animals from some tests?</p><p>3, The authors did not show any post-hoc images of the virus injection/expression and co-localization with cell type specific markers for all the functional manipulation and imaging studies. These should be provided to substantiate the results.</p><p>4, In Figure 4 supplement 1B: Chemogenetic inhibition of CeA-SST neurons does not affect the paw withdrawal response in the naïve mice. In contrast, the authors themselves showed in their recent paper that optogenetic inhibition of CeA-SST neurons increased paw withdrawal response (Chen et al., 2022, Pain). Please reconcile these two different results in the same lab.</p><p>5, There is no data on a2d VGCC subunit expression in parabrachial or CeA in the chronic MP model in this manuscript. Given so much emphasis on PGB results, this information is crucial and is missing here.</p><p>6, The authors performed the in vivo calcium imaging of CeA-SST neurons in response to PGB. It would be more informative to know how CeA-SST neurons or CeA-PKCd neurons respond to 1st and 2nd acid injection.</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Cellular Mechanisms Underlying Central Sensitization in a Mouse Model of Chronic Muscle Pain&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Gary Westbrook (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined here and in the novel comments by the reviewers:</p><p>Essential revisions:</p><p>All the reviewers acknowledged that the Authors replied satisfactorily to most of their comments and that the first revised version is improved. However, they also concur that the manuscript still needs some significant improvements.</p><p>Specifically:</p><p>1) The text is often hard to read and should be carefully checked to improve readability. If needed, a professional writer could be helpful.</p><p>2) All the reviewers acknowledged the additional excel database and your explanations regarding the data in Figure 3 – supplement 2 B-D. These data were submitted to support the electrophysiological results – that SST+ neuron excitability is selectively enhanced in MP mice. (See also comments of Reviewer 3 in their original review)</p><p>However, some improvements are needed:</p><p>a) We think that you pooled the data from &quot;all slices&quot; together at a given AP position relative to Bregma, to generate the plots and calculate SEM. However, we think you should re-calculate the mean at each AP position for each animal first, then average across animals and calculate SEM. In this way, the data would be averaged within an animal and the variance would be calculated between animals in order to assess the robustness of the results;</p><p>b) Explain why the number of slices at a given AP position varies dramatically across animals (some animals have 1 slice, some have 5-9 slices at a given AP-position). Furthermore, how it could be that in some mice the AP position has 5-9 slices, whereas from the method one can calculate that a maximum of 3 slices can be obtained for a given AP position;</p><p>c) The number of samples for each bregma level and animal should be similar and more control data should be collected and included since currently they show large variability;</p><p>d) Statistical analysis should be improved, e.g. a two-factor analysis of variance (with equal replications) would be a good way to analyze these data.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>I think that the Authors have done a good job in revising the manuscript according to my suggestions.</p><p>Specifically:</p><p>1) They further investigated and analyzed synaptic transmission at the PBN input to the CeA. The data suggest that the PBN input is not the major potentiated input onto the CeA-SST neurons in the MP mice. They also compared the effect of PGB inhibition between the Ctrl and MP groups and found it similar. Then, they tested the effect of PGB on synaptic transmission at the PBN-CeAPKCδ neuron synapses. Approximately 30% CeA-PKCδ neurons were sensitive to PGB inhibition in the Ctrl mice and approximately 63% CeA-PKCδ neurons were sensitive to PGB inhibition in the MP mice.</p><p>2) Potential changes in intrinsic excitability of CeA-SST neurons are discussed in the revised version of the manuscript.</p><p>3) The Authors strengthen the interpretation of enhancement of vesicle release at the inputs onto the CeA-SST neuron synapses along with the increased excitability to account for the central sensitization of the CeA-SST neurons in MP.</p><p>4) They addressed the issue of PGB mediated increase in paw withdraw threshold and emotion behaviors.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The work by Lin and coworkers addresses the important and of broad interest process that underlies the progression of transient pain into persistent pain. This study used a number of sophisticated techniques to dissect the synaptic and cellular mechanisms that occur in the mouse central amygdala (CeA) during the development of chronic muscle pain. In particular, the study reveals shifts in opposite directions of the activity of somatostatin-expressing (SST+) and PKCδ+ neurons. Pharmacological and chemogenetic manipulation of these neurons prevented the chronification of pain and of the comorbid affective behaviors, although with important differences between these two neuronal classes.</p><p>In their revised manuscript, the authors have made a number of significant changes by which they could adequately address my main concerns. In particular, the additional experimental data aimed at increasing the sample size of the behavioural experiments has appreciably improved the manuscript.</p><p>While the text has improved, it still contains several syntax and grammar errors that need to be corrected.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>In the revised manuscript, the authors addressed most of my previous concerns. In their response to my question of conflicting results for inhibition of CeA-SST neurons from their prior publication, they responded that &quot;It seems that different illumination protocols resulted in opposite behaviors&quot;. &quot;5 min optogenetic inhibition of CeA-SST reduced mechanical sensitivity, while 10 min illumination increased mechanical sensitivity&quot;. I honestly cannot think of any known mechanism that could explain opposing effect induced by 5min vs 10min optogenetic inhibition. I give up.</p><p>I do have some questions for Figure 3—figure supplement 2</p><p>In D, the number of SST(-)pERK(+) in the Ctrl (-1.82 mm) is above 40, while in B, the number of total pERK(+) in the Ctrl (-1.82mm) is about 30. This is weird. How could total number of pERK<sup>+</sup> cells in B being less than that in D (a subset of neurons)?</p><p>Authors concluded in Line 212-213, &quot;increased pERK-positive cells are mostly CeA-SST cells.&quot; From the results shown in C and D, it's difficult to be convinced of this statement: the number of SST(+) pERK(+) cells increased from 1.1 to 3.7, while SST(-) pERK(+) cells increased from 18 to 28, even though statistics appeared to be not significant. I believe that instead of comparing the averaged number across sections, comparing the total number of cells in the CeA makes more sense.</p><p>The &quot;gray&quot; bars for &quot;control&quot; samples in panel B (total pERK<sup>+</sup>) and in panel D (SST-/pERK<sup>+</sup>) appear identical. Could there be an image duplication here?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78610.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The investigation of the direct monosynaptic excitatory input from the PBN to CeA neurons should be completed by recordings from PKCd+ neurons. Furthermore, more statistical analyses of the data already submitted should be performed, as explained by Reviewer 1.</p></disp-quote><p>In the revised version of the manuscript, we completed the investigation of the direct monosynaptic excitatory input from the PBN to the CeA-PKCδ neurons (Figure 5 —figure supplement 1). As the reviewer #1 suggested, we also performed additional statistical analyses of the data (see our response to the reviewer #1).</p><disp-quote content-type="editor-comment"><p>2) Increase the number of animals used with chronic muscle pain treated with PGB for the EPM and sociability behavioral tests.</p></disp-quote><p>In the revised version of the manuscript, we increased the number of experiments in Figure 2B (Ctrl-ACSF, from n = 5 to 6; Ctrl-PGB, from n = 4 to 6; MP-ACSF, from n = 5 to 7; MP-PGB, from n = 6 to 7) and 2E (Ctrl-ACSF, from n = 5 to 6; Ctrl-PGB, from n = 5 to 7; MP-ACSF, from n = 4 to 6; MP-PGB, from n = 5 to 6).</p><disp-quote content-type="editor-comment"><p>3) Provide control data on post-hoc images of the virus injection/expression and co-localization with cell type specific markers; refer to previously published data or publicly available data (Allen Inst) on a2d VGCC subunit expression in parabrachial -CeA.</p></disp-quote><p>We added images of virus expression (AAV5-hSyn-hM4Di-mCherry or AAV5-hSyn-hM3Dq-mCherry) colocalized with cell type specific markers (SST or PKCδ) in Figure 4B and Figure 4 —figure supplement 4B in the revised submission. The colocalization of specific markers with virus expression was summarized in Figure 4 —figure supplement 1 and 4B in the revised submission.</p><p>Regarding the α2δ VGCC subunit expression, we cited a previous study by Cole et al. (2005), which demonstrated the anatomical distribution of α2δ VGCC subunit expression across the whole rat brain (page 5, line 1 – 2). Moreover, we provided the published data by Allen Brain Institute, which demonstrated α2δ1 and α2δ2 VGCC subunit expression in the parabrachial nucleus in our supplement file (Figure 1 —figure supplement 2).</p><disp-quote content-type="editor-comment"><p>4) Better discuss: acute PGB effect on the mechano-sensitivity versus emotional behavior; mechanisms involved in changes in intrinsic excitability of neurons in the MP model; pre- versus pot-synaptic changes detected in the MP model; the source(s) of the spontaneous synaptic events.</p></disp-quote><p>In the revised version of manuscript, we included discussions on acute PGB effect on the mechano-sensitivity versus emotional behavior (Figure 2 —figure supplement 1; page 9, line 16 – 33), mechanisms involved in changes in intrinsic excitability of neurons in the MP model (page 10, line 24 – 37), pre- versus post-synaptic changes detected in the MP model (page 9, line 35 – 49; page 10, line 1 – 23), and the source(s) of the spontaneous synaptic events (page 10, line 11 – 23). Please also refer to our response to the Reviewer #1 (point #1 – 5).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1) The direct monosynaptic excitatory input from the parabrachial nucleus (PBN), which is enriched with the calcium channel α2δ subunit, onto CeA neurons, is directly investigated by presynaptic optogenetic stimulation and postsynaptic recordings of SST neurons (Figure 5B). I think this is an important approach that should be further exploited. From the data submitted, it seems that such evoked EPSCs are about 3 times bigger in MP mice compared to controls. Provided that optogenetically-evoked EPSCs from control and MP mice could be appropriately compared, e.g. through normalization, is this difference statistically significant?</p><p>It would be also useful to statistically compare the inhibition of the evoked EPSCs by PGB in the two genotypes. Finally, could the Authors perform some more experiments and report the results of a similar experiment by recording from PKCδ neurons, and statistically compare it to the evoked EPSCs recorded in SST neurons?</p></disp-quote><p>In revision, we further investigated and analyzed synaptic transmission at the PBN input to the CeA. First, we found the average EPSC amplitude was 1.5 times greater in the MP mice compared to the Ctrl mice. However, the change did not reach the statistical significance (Ctrl, 73.9 ± 17.9 pA, n = 8; MP, 110.7 ± 20.0 pA, n = 8; Mann–Whitney test, U = 17, n.s., non-significant, <italic>p</italic> = 0.13; Figure 5 —figure supplement 2A). Moreover, the PPR of the light-evoked EPSCs recorded at the PBN-CeA-SST neuron synapses showed no change in the Ctrl and MP groups (Ctrl, 0.65 ± 0.04, n = 8; MP, 0.60 ± 0.02, n = 8; Mann–Whitney test, U = 25, n.s., non-significant, <italic>p</italic> = 0.49). These results may suggest that the PBN input is not the major potentiated input onto the CeA-SST neurons in the MP mice. However, it is worth noting that the CeA-SST neurons were randomly selected for recording. It is very possible that not all recorded CeA-SST neurons were sensitized neurons. Therefore, we need to carefully interpret our data.</p><p>Second, we compared the effect of PGB inhibition between the Ctrl and MP groups (Figure 5C). Bath application of PGB (500 µM) decreased the amplitude of light-evoked EPSCs in some CeA-SST neurons of both the Ctrl and MP mice (Figure 5B). Overall, the percentage of PGB-sensitive neurons was only slightly increased in the MP mice (Figure 5C left; Ctrl mice, 37%; 8 cells from 5 mice vs. MP mice, 63%; 8 cells from 4 mice; Chi-square test, <italic>p</italic> = 0.317) and the degree of inhibition between these two groups was similar (Ctrl, 24.9 ± 5.3 %, n = 3; MP, 30.1 ± 5.5 %, n = 5; Mann–Whitney test, U = 5, n.s., non-significant, <italic>p</italic> = 0.5).</p><p>Finally, we tested the effect of PGB on synaptic transmission at the PBN-CeA-PKCδ neuron synapses. The amplitude of the light-evoked EPSCs recorded at the PBN-CeA-PKCδ neuron synapses was decreased in the MP group (Ctrl, 134.2 ± 13.2 pA, n = 10; MP, 75.7 ± 14.5 pA, n = 8; Mann–Whitney test, U = 12, *<italic>p</italic> = 0.01; Figure 5 —figure supplement 2C). However, the paired-pulse ratio of the light-evoked EPSCs recorded at the PBN-CeA-PKCδ neuron synapses was not different between the Ctrl and MP groups (Ctrl, 0.62 ± 0.06, n = 10; MP, 0.52 ± 0.08, n = 8; Mann–Whitney test, U = 28, n.s., non-significant, <italic>p</italic> = 0.31; Figure 5 —figure supplement 2D). Compared to the amplitude of the light-evoked EPSCs at the PBN-CeA-SST neuron synapses, the light-evoked EPSCs amplitude of the CeA-PKCδ neurons was increased in the Ctrl mice (SST, 73.9 ± 17.9 pA, n = 8; PKCδ, 134.2 ± 13.2 pA, n = 10; Mann–Whitney test, U = 13, *<italic>p</italic> = 0.016; Figure 5 —figure supplement 2E), but showed no significant change in the MP mice (SST, 110.7 ± 20.0 pA, n = 8; PKCδ, 75.7 ± 14.5 pA, n = 8; Mann–Whitney test, U = 19, <italic>p</italic> = 0.19; Figure 5 —figure supplement 2F). In addition, the paired-pulse ratio of the light-evoked EPSCs recorded at the synapses of the PBN-CeA-PKCδ neurons and PBN-CeA-SST neurons were not different between the Ctrl (SST, 0.65 ± 0.04, n = 8; PKCδ, 0.62 ± 0.06, n = 10; Mann–Whitney test, U = 18, n.s., non-significant, <italic>p</italic> = 0.054; Figure 5 —figure supplement 2G) and MP groups (SST, 0.60 ± 0.02, n = 8; PKCδ, 0.52 ± 0.08, n = 8; Mann–Whitney test, U = 28, n.s., non-significant, <italic>p</italic> = 0.7; Figure 5 —figure supplement 2H). Bath application of PGB decreased the amplitude of light-evoked EPSCs in the CeA-PKCδ neurons of both the Ctrl and MP mice (Figure 5 —figure supplement 1B, D). Approximately 30% CeA-PKCδ neurons were sensitive to PGB inhibition in the Ctrl mice and approximately 63% CeA-PKCδ neurons were sensitive to PGB inhibition in the MP mice (Figure 5 —figure supplement 1C). Furthermore, the degree of inhibition between these two groups were similar (Figure 5 —figure supplement 1C). Consistent with the effect of PGB on presynaptic α2δ subunit of VGCCs, the reduction of EPSCs was concomitant with an increase in the paired-pulse ratio (Figure 5 —figure supplement 1E).</p><disp-quote content-type="editor-comment"><p>2) What mechanisms the Authors envisage to account for by the changes in intrinsic excitability in SST+ and PKCδ neurons observed in MP mice? This aspect should be discussed.</p></disp-quote><p>Several molecular mechanisms underlying aberrant plasticity of sensitized neurons were reported in different chronic pain animal models (Min et al. 2011; Sun and Chen, 2016; Cheng et al., 2011; Fu et al., 2008). These changes include synaptic and intrinsic plasticity. We reported that increased spike number in response to current injection and reduced rheobase in the CeA-SST neurons in the MP mice (Figure 3), whereas their input resistance and resting potential were unaltered (Figure 3 —figure supplement 1). Therefore, we speculate that some active conductances such as voltage-gated sodium channels are upregulated in the CeA-SST neurons of the MP mice. It is worth noting that increased excitability was specific to early-spiking (ES) neurons, the subtype of CeA-SST neurons in the MP mice. Conversely, the decreased excitability was specific to the ES type of PKCδ neurons. According to previous studies, modifications of intrinsic excitability are likely dependent on the PKC-ERK pathway (Min et al. 2011; Cheng et al., 2011). We discussed the possible mechanisms in Discussion (page 10, line 7 – 37).</p><p>References:</p><p>Min MY, Yang HW, Yen CT, Chen CC, Chen CC, Cheng SJ. (2011). ERK, synaptic plasticity and acid-induced muscle pain. Commun Integr Biol <italic>4</italic>, 394–396. Doi: 10.4161/cib.4.4.15694.</p><p>Sun, WH, and Chen, CC. (2016). Roles of Proton-Sensing Receptors in the Transition from Acute to Chronic Pain. J Dent Res <italic>95</italic>, 135–142. Doi: 10.1177/0022034515618382.</p><p>Cheng SJ, Chen CC, Yang HW, Chang YT, Bai SW, Chen CC, Yen CT, Min MY. (2011). Role of extracellular signal-regulated kinase in synaptic transmission and plasticity of a nociceptive input on capsular central amygdaloid neurons in normal and acid-induced muscle pain mice. J Neurosci <italic>31</italic>, 2258–2270. Doi: 10.1523/JNEUROSCI.5564-10.2011.</p><p>Fu Y, Han J, Ishola T, Scerbo M, Adwanikar H, Ramsey C, Neugebauer V. (2008). PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol Pain <italic>4</italic>, 26. Doi: 10.1186/1744-8069-4-26.</p><disp-quote content-type="editor-comment"><p>3) The Authors reported effects on amplitude and/or frequency of sEPSCs and mEPSCs onto CeA recorded neurons seem to suggest a presynaptic mechanism of action. In contrast, the effect of PGB on calcium transient revealed by 1P deep calcium imaging may be interpreted as pre and/or postsynaptic.</p><p>The Authors should make a more definitive conclusion whether they think their data suggest a presynaptic only or also a postsynaptic mechanism of action. It may be difficult to draw any conclusion from sEPSCs since these events are probably due to the release of multiple synaptic vesicles (e.g., mean amplitude of sEPSCs is bigger than the mean amplitude of mEPSCs).</p></disp-quote><p>Our data showed that PGB suppressed synaptic transmission and increased the PPR at the PBN-CeA-SST neuron synapses (Figure 5). Therefore, we interpreted the suppression of calcium transients in the CeA-SST neurons by PGB was mediated by presynaptic inhibition (also see page 8, line 5 – 7).</p><p>Regarding the mechanism of synaptic plasticity, we reported that both the sEPSC and mEPSC frequency were increased in the CeA-SST neurons. Therefore, the enhancement of vesicle release at the inputs onto the CeA-SST neuron synapses along with the increased excitability might mainly account for the central sensitization of the CeA-SST neurons in MP (page 9, line 35 – 49; page 10, line 1 – 23).</p><disp-quote content-type="editor-comment"><p>4) The Authors should discuss the possible source(s) of the spontaneous synaptic events. Do they only originate from PBN terminals or also from BLA principal neurons or elsewhere? Is an analysis of mEPSCs kinetics compatible with an homogeneous pool of presynaptic terminals as source of the m/sEPSCs or rather SST+ and PKCδ+ neurons are biophysically too compact to make out the presence of heterogeneous excitatory inputs perhaps impinging on different spatial domains of the neurons' dendritic trees?</p></disp-quote><p>In revision, we discussed the possible sources of the spontaneous synaptic events (see below; also page 10, line 11 – 23 in the Discussion). Several excitatory inputs impinge onto CeA neurons (Fadok et al., 2018). The CeA receives nociceptive inputs from the dorsal horn via the PBN and affect-related information from the LA (Li et al., 2020; Wilson et al., 2019; Ikeda et al., 2007). The PBN-CeA synaptic potentiation is consolidated in chronic neuropathic pain (Ikeda et al., 2007). In addition, BLA-CeA synapses are potentiated in chronic neuropathic pain (Ikeda et al., 2007). The PVT, which is a structure that is readily activated by both physical and psychological stressors, also projects to the CeA (Penzo et al., 2015). Taken together, our results revealed that the net synaptic efficacy of the PBN-CeA, PVT-CeA or BLA-CeA synapses onto CeA-SST neurons were strengthened, whereas the synapses onto CeA-PKCδ neurons were weakened in chronic muscle pain.</p><p>Our preliminary analysis of sEPSC decay time revealed at least two populations of sEPSCs, suggesting heterogeneous excitatory inputs impinging on different spatial domain of the neuron’s dendrites (Figure 3 —figure supplement 3).</p><p>References:</p><p>Fadok JP, Markovic M, Tovote P, Lüthi A. (2018). New perspectives on central amygdala function. Curr Opin Neurobiol <italic>49</italic>, 141–147. Doi: 10.1016/j.conb.2018.02.009.</p><p>Li JN, and Sheets PL. (2020). Spared nerve injury differentially alters parabrachial monosynaptic excitatory inputs to molecularly specific neurons in distinct subregions of the central amygdala. Pain <italic>161</italic>, 166–176. Doi: 10.1097/j.pain.0000000000001691.</p><p>Wilson TD, Valdivia S, Khan A, Ahn HS, Adke AP, Martinez Gonzalez S, Sugimura YK, Carrasquillo Y. (2019). Dual and opposing functions of the central amygdala in the modulation of pain. Cell Rep <italic>29</italic>, 332–346.e5. Doi: 10.1016/j.celrep.2019.09.011.</p><p>Ikeda R, Takahashi Y, Inoue K, Kato F. (2007). NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain. Pain <italic>127</italic>, 161–172. Doi: 10.1016/j.pain.2006.09.003.</p><p>Penzo MA, Robert V, Tucciarone J, De Bundel D, Wang M, Van Aelst L, Darvas M, Parada LF, Palmiter RD, He M, Huang ZJ, Li B. (2015). The paraventricular thalamus controls a central amygdala fear circuit. Nature <italic>519</italic>, 455–459. Doi: 10.1038/nature13978.</p><disp-quote content-type="editor-comment"><p>5) The paw withdraw effect could be replicated by either reducing the CeA SST+ cell activity or by elevating PKCd+ cell activity, but this is not the case for the anxiety-like affective behaviors (Figure 4, Figure 4 S2). Therefore, the PGB effect on the increased paw withdraw threshold and emotion behaviors in the MP mouse model may be caused by distinct circuit mechanisms occurring simultaneously.</p><p>To further elucidate their observation, the Author should test the acute PGB effect on the mechano-sensitivity and emotional behavior separately using a wild type mice or should at least acknowledge this possibility in the discussion.</p></disp-quote><p>Distinct circuit mechanisms could account for the increased paw withdraw threshold and improved emotion behaviors in the MP mouse model by PGB because PGB treatment is not specific to the inputs onto the CeA-SST neurons. Nevertheless, our Figure 2 —figure supplement 1 provides a parsimonious explanation for the effect of PGB on the increased paw withdraw threshold and emotion behaviors.</p><p>Regarding the PGB effect on mechano-sensitivity and emotional behavior, we plotted the changes of immobility time in the FST or number of buried marbles in the marble burying test against the change of mechano-sensitivity. Only the data obtained from the FST and marble burying test were used to address this question because these two behavioral assays could be tested before and after PGB application on the same animals. After PGB application, no positive correlation was observed between the change of the PW threshold and the change of the immobility time. A weak positive correlation between the change of PW threshold and the change in the number of buried marbles (Figure 2 —figure supplement 1), suggests that PGB alleviates the mechano-sensitivity and emotional behavior through distinct circuit mechanisms (see the Discussion page 9; line 16 – 33). For the EPM and social avoidance, the results can be influenced by repeated tests. Therefore, animals were only tested with either ACSF or PGB.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>My specific issues are outlined below:</p><p>1) Why does the number of animals tested in the different behavioural paradigms (relative to Figures2 and 4) vary from test to test? Were these different cohorts for each behavioural test?</p></disp-quote><p>We indeed had different cohorts of mice for each behavioral test. This is somehow inevitable during the development of a project. For the same cohort, we randomly and equally assigned animals to the MP and Ctrl groups and then performed behavioral tests. Initially we focused on some common anxiety-like behavioral tests such as the EPM, L/D box, and marble burying tests. After obtaining positive results, we decided to add additional behavioral tests to strengthen the face validity of this pain model. Anxiety disorders are often associated with depression-like behavior and social avoidance. Therefore, we added the FST for depression and the three-chamber test for sociability. Addition of different cohorts for each behavioral test accounts for different numbers of animals in the different paradigms.</p><disp-quote content-type="editor-comment"><p>2) The size of the cohorts in which PGB was tested (and the relative controls) after induction of chronic muscle pain (Figure 2A-E) is suboptimal for the EPM and sociability tests, also in view of the known relatively high interindividual variability, and should, therefore, be increased.</p></disp-quote><p>We agree with the reviewer that the size of the cohorts is suboptimal for the EPM and sociability tests (Figure 2A–E). In revision, we increased the number of experiments in Figure 2B (Ctrl-ACSF, from n = 5 to 6; Ctrl-PGB, from n = 4 to 6; MP-ACSF, from n = 5 to 7; MP-PGB, from n = 6 to 7) and 2E (Ctrl-ACSF, from n = 5 to 6; Ctrl-PGB, from n = 5 to 7; MP-ACSF, from n = 4 to 6; MP-PGB, from n = 5 to 6). The following is the summary of the results.</p><p>Compared to the Ctrl mice, cannula infusion of PGB into the CeA of the MP mice increased the open-arm time in the EPM test (Ctrl: ACSF, 29.6 ± 3.8 %, n = 6; PGB, 20.0 ± 2.7 %, n = 5; Mann–Whitney test, U = 4, n.s., non-significant, <italic>p</italic> = 0.052. MP: ACSF, 15.1 ± 3.0 %, n = 7; PGB, 38.4 ± 5.1 %, n = 7; Mann–Whitney test, U = 2, **<italic>p</italic> = 0.002; Figure 2B) and increased the social-zone time in the three-chamber social test (Ctrl: ACSF, 44.6 ± 4.8 %, n = 6; PGB, 37.8 ± 3.8 %, n = 7; Mann–Whitney test, U = 10, n.s., non-significant, <italic>p</italic> = 0.138. MP: ACSF, 34.2 ± 2.9 %, n = 6; PGB, 48.6 ± 5.0 %, n = 6; Mann–Whitney test, U = 5, *<italic>p</italic> = 0.041; Figure 2E). PGB at the dosage used in this study had no effect on the locomotion (Figure 2B; Ctrl: ACSF, 24.1 ± 2.9 m, n = 6; PGB, 22.9 ± 2.1 m, n = 5; Mann–Whitney test, U = 14, n.s., non-significant, p = 0.875. MP: ACSF, 21.4 ± 1.0 m, n = 7; PGB, 22.7 ± 2.3 m, n = 7; Mann–Whitney test, U = 18, n.s., non-significant, <italic>p</italic> = 0.446 Figure 2E; Ctrl: ACSF, 42.3 ± 2.3 m, n = 6; PGB, 35.2 ± 2.7 m, n = 7; Mann–Whitney test, U = 9, n.s., non-significant, <italic>p</italic> = 0.101. MP: ACSF, 39.5 ± 2.8 m, n = 6; PGB, 38.0 ± 3.6 m, n = 6; Mann–Whitney test, U = 15, n.s., non-significant, <italic>p</italic> = 0.675).</p><disp-quote content-type="editor-comment"><p>3) It should be made more clear in the text that in vivo ca<sup>2+</sup> imaging experiments were performed in mice with chronic muscle pain. Why did the authors did not test the effect of PGB on SST+ neuron activity in control animals? This would have strengthened their findings. Moreover, they could have better exploited their study by testing the effect of PGB on SST+ neuron activity during a von Frey filament stimulation, as this test offers good behavioral bouts in which to analyse ca<sup>2+</sup> transients.</p></disp-quote><p>Compared to the MP group, PGB had little effect on the mechanical sensitivity (Figure 1E, 1F) and affective behaviors (Figure 2B–E) in the Ctrl mice. Our finding suggests that PGB preferentially exerted its effect on the rewired pain/emotional circuits.</p><p>We do agree that the reviewer raised an important question. Compared to the rewired circuitry in the MP mice, the effect of PGB on neuronal activity in the Ctrl mice could be different. Considering that PGB had little effect on pain behavior in the Ctrl mice, we speculate that PGB could exert a marginal effect on SST neuron activity in the Ctrl mice. Nevertheless, we agree with the reviewer that testing the effect of PGB on SST+ neuron activity in the control mice would strengthen our findings and should be addressed in the future.</p><p>Regarding testing the effect of PGB on SST+ neuron activity during a von Frey filament stimulation, we agree that this experiment is interesting. Also, it may offer good behavioral bouts for detecting mechanically evoked ca<sup>2+</sup> transients. In this study, we focused on maladaptive changes of pro-nociceptive neurons (that is, SST+ neurons) during the development chronic muscle pain. Therefore, we did not test the nociceptive response of the SST+ neurons in response to acute nociceptive stimulation such as acid injection.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>I have the following comments, which require more experiments to address in order to make the manuscript more convincing.</p><p>1, Figure 3 shows recording results from CeA-SST and CeA-PKCd neurons in the MP mice. Since these neurons at baseline consist of different firing phenotypes (spontaneous, late-firing, and regular firing), it would be useful to know whether all firing types show the same changes in synaptic transmission and excitability in the MP model.</p><p>Notably, in Wilson et al., 2019 paper, they found that CeA neurons require at least 50-80 pA current injection to induce the spikes, whereas in this manuscript, CeA neurons require a much lower current injection to fire. Could the author provide some explanation to this difference?</p></disp-quote><p>According to our previous study (Hou et al., 2016), we analyzed all CeA neurons shown in Figure 3 and classified them into early-spiking (ES) and late-spiking (LS) neurons based on their spike delay at rheobase. Using the same criteria, the CeA neurons with a spike delay greater than 1.5 s were classified as LS neurons, while the rest were classified as ES neurons (see Figure 3 —figure supplement 4). The ratio of these two subpopulations (ES vs. LS type) was not significantly altered in the MP mice.</p><p>For the changes in excitatory synaptic transmission (panel A and B in Figure 3 —figure supplement 4), compared to the Ctrl mice, sEPSC frequency was increased in SST-ES neurons of the MP mice (Ctrl, 1.3 ± 0.1 Hz, n = 4; MP, 3.5 ± 0.6 Hz, n = 9; Mann–Whitney test, U = 1, **<italic>p</italic> = 0.006). However, the sEPSC amplitude recorded from SST-ES neurons in the MP mice was not significantly different from that in Ctrl mice (Ctrl, 14.6 ± 3.0 pA, n = 4; MP, 16.9 ± 1.8 pA, n = 9; Mann–Whitney test, U = 14, <italic>p</italic> = 0.548). In contrast, the mean frequency (Ctrl, 2.8 ± 0.8 Hz, n = 5; MP, 4.9 ± 1.0 Hz, n = 11; Mann–Whitney test, U = 14, <italic>p</italic> = 0.138) and amplitude (Ctrl, 15.1 ± 2.6 pA, n = 5; MP, 16.9 ± 1.5 pA, n = 11; Mann–Whitney test, U = 23, <italic>p</italic> = 0.617) of SST-LS neurons in the MP mice were similar to those in the Ctrl mice.</p><p>On the other hand, sEPSC frequency in PKCδ-ES neurons of the MP mice was unchanged compared to the Ctrl mice (Ctrl, 4.5 ± 2.2 Hz, n = 3; MP, 1.7 ± 0.4 Hz, n = 7; Mann–Whitney test, U = 5, <italic>p</italic> = 0.267). Similarly, the sEPSC amplitude in PKCδ-ES neurons of the MP mice was not significantly different from that in the Ctrl mice (Ctrl, 17.1 ± 1.6 pA, n = 3; MP, 15.2 ± 1.3 pA, n = 7; Mann–Whitney test, U = 5, <italic>p</italic> = 0.267). In contrast, sEPSC frequency in PKCδ-LS neurons of the MP mice was significantly decreased compared to the Ctrl mice (Ctrl, 5.3 ± 1.0 Hz, n = 6; MP, 2.6 ± 0.3 Hz, n = 13; Mann–Whitney test, U = 13, *<italic>p</italic> = 0.022). However, sEPSC amplitude in PKCδ-LS neurons of the MP mice was unchanged compared to the Ctrl mice (Ctrl, 16.3 ± 0.6 pA, n = 6; MP, 15.2 ± 1.3 pA, n = 13; Mann–Whitney test, U = 30, <italic>p</italic> = 0.47). Taken together, the upregulated excitatory transmission was specific to SST-ES neurons, whereas downregulated excitatory transmission was specific to PKCδ-LS neurons.</p><p>For the changes in cell excitability (panel C and D in Figure 3 —figure supplement 4), the SST-ES neurons in the MP mice generated more action potentials in response to depolarizing current injections compared to those in the Ctrl mice (Ctrl, n = 6; MP, n = 12; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,78) = 10.84, **<italic>p</italic> = 0.0015). In agreement with increased excitability, the rheobase of SST-ES neurons in the MP mice was significantly lower than those in the Ctrl mice (Ctrl, 59.7 ± 9.5 pA, n = 6; MP, 34.2 ± 6.0 pA, n = 12; Mann–Whitney test, U = 11.5, *<italic>p</italic> = 0.02). Intriguingly, the number of evoked spikes (Ctrl, n = 9; MP, n = 16; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,114) = 1.618, <italic>p</italic> = 0.206) and rheobase of SST-LS neurons (Ctrl, 53.0 ± 8.4 pA, n = 9; MP, 42.1 ± 5.6 pA, n = 16; Mann–Whitney test, U = 52.5, <italic>p</italic> = 0.282) in the MP mice were similar to those in the Ctrl mice.</p><p>In great contrast to SST-ES neurons in the MP mice, the PKCδ-ES neurons in the MP mice generated less action potentials in response to depolarizing current injections compared to those in the Ctrl mice (Ctrl, n = 4; MP, n = 7; two-way ANOVA with Bonferroni’s multiple comparison test, F(1,45) = 16.4, ***<italic>p</italic> = 0.0002). However, the rheobase of PKCδ-ES neurons in the MP mice was comparable to those in the Ctrl mice (Ctrl, 33.8 ± 3.1 pA, n = 4; MP, 63.0 ± 13.0 pA, n = 5; Mann–Whitney test, U = 3, <italic>p</italic> = 0.127). Similar to SST-LS neurons, the spike number (Ctrl, n = 7; MP, n = 13; two-way ANOVA with Bonferroni's multiple comparison test, F(1,88) = 2.84, <italic>p</italic> = 0.096) and rheobase (Ctrl, 30.8 ± 7.9 pA, n = 6; MP, 44.1 ± 4.0 pA, n = 12; Mann–Whitney test, U = 20.5, <italic>p</italic> = 0.157) of PKCδ-LS neurons in the MP mice were similar to those in the Ctrl mice. Taken together, the modification of cell excitability in the MP mice is specific to ES neurons in both CeA-SST and CeA-PKCδ neurons.</p><p>Regarding the difference in current threshold for spike generation, the rheobase was measured in the presence of synaptic GABAA (1 μM) and GABAB (1 μM) receptor blockers in our study. In contrast, spikes were evoked in the absence of synaptic blockers in the study by Wilson et al. (2019). Therefore, reduced inhibition in our recordings could account for the requirement of a much lower current injection for spike generation.</p><p>References:</p><p>Hou WH, Kuo N, Fang GW, Huang HS, Wu KP, Zimmer A, Cheng JK, Lien CC. (2016). Wiring specificity and synaptic diversity in the mouse lateral central amygdala. J Neurosci <italic>36</italic>, 4549–4563. Doi: 10.1523/JNEUROSCI.3309-15.2016.</p><p>Wilson TD, Valdivia S, Khan A, Ahn HS, Adke AP, Martinez Gonzalez S, Sugimura YK, Carrasquillo Y. (2019). Dual and opposing functions of the central amygdala in the modulation of pain. Cell Rep <italic>29</italic>, 332–346.e5. Doi: 10.1016/j.celrep.2019.09.011.</p><disp-quote content-type="editor-comment"><p>2, The number of animals in each test is quite different. For instance, in Figure 4E, n=10 for the mCherry group and n=52 for the hM4Di group; this is a big difference to compare 2 groups. Also, in Figure 4 supplement 2, in the CeA-PKCd experiment, n=4 for the mCherry group and n=13 for the hM3q group. These numbers are significantly fewer than those for CeA-SST hM4Di group (n=52). Please explain how the numbers of animals were assigned to each test? Did the author exclude some animals from some tests?</p></disp-quote><p>We designed two types of experiments to test the effect of silencing the CeA-SST neurons. Initially we tested the hM4Di effect on the MP mice (n = 43, Figure 4 —figure supplement 2). To this end, we expressed hM4Di on the SST neurons and then tested the effects of VEH (saline, i.p.) vs. CNO (i.p.) on the mechanical sensitivity in the MP mice. The result suggested that silencing the CeA-SST neurons by CNO reduces mechanical hypersensitivity. However, a potential caveat of this experiment is the off-target effect of CNO (Manvich et al., 2018). Therefore, we performed another group of experiments, in which we tested the effect of CNO on the mCherry- and mCherry-hM4Di- expressing MP mice (mCherry, n = 10; hM4Di, n = 9; Figure 4E).</p><p>In the originally submitted manuscript, we pooled the data obtained from the mCherry-hM4Di-expressing MP mice, which received the CNO treatment from the two experimental groups (n = 43 vs. 9). In revision, we separated the results of these two sets of experiment results. We only showed the CNO effect on the mCherry- and hM4Di-expressing MP mice (mCherry, n = 10; hM4Di, n = 9) in Figure 4E. Since the result is sufficient to support our conclusion, we moved the data, which compared the CNO vs. vehicle on the hM4Di-expressing MP mice, to the supplemental part (n = 43; Figure 4 —figure supplement 2).</p><p>References:</p><p>Manvich DF, Webster KA, Foster SL, Farrell MS, Ritchie JC, Porter JH, Weinshenker D. (2018). The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice. Sci Rep <italic>8</italic>, 3840. Doi.org/10.1038/s41598-018-22116-z.</p><disp-quote content-type="editor-comment"><p>3, The authors did not show any post-hoc images of the virus injection/expression and co-localization with cell type specific markers for all the functional manipulation and imaging studies. These should be provided to substantiate the results.</p></disp-quote><p>In revision, we added images of virus expression (AAV5–hSyn-hM4Di-mCherry or AAV5–hSyn-hM3Dq-mCherry) colocalized with cell type specific markers (SST or PKCδ) in Figure 4B and Figure 4 —figure supplement 1A, 4B in the revised submission. The colocalization of specific markers with virus expression was summarized in Figure 4 —figure supplement 1B and 4B in the revised submission. Briefly, we injected an AAV5–hsyn-hM4Di-mCherry virus into the CeA of SST-Cre mice and performed SST immunohistochemistry (IHC) after virus expression (Figure 4B and Figure 4 —figure supplement 1). Our results revealed that 79.68 ± 1.87 % mCherry<sup>+</sup> cells in the CeA are SST immunoreactive. Conversely, 63.63 ± 3.83 % SST-immunoreactive cells in the CeA are mCherry<sup>+</sup> cells (SST+mCherry/SST, 63.63 ± 3.83 %; SST+mCherry/mCherry, 79.68 ± 1.87 %; n = 18 slice from two mice).</p><p>On the other hand, we injected an AAV5–hsyn-hM3Dq-mCherry virus into the CeA of PKCδ-Cre mice and performed PKCδ IHC after virus expression (Figure 4 —figure supplement 4B in the revised submission). Our results revealed that 62.73 ± 2.09 % mCherry<sup>+</sup> cells in the CeA are PKCδ immunoreactive. Conversely, 34.11 ± 1.86 % PKCδ-immunoreactive cells in the CeA are the mCherry<sup>+</sup> cells (PKCδ+mCherry/PKCδ, 34.11 ± 1.86 %; PKCδ+mCherry/mCherry, 62.73 ± 2.09 %; n = 21 slice from two mice).</p><disp-quote content-type="editor-comment"><p>4, In Figure 4 supplement 1B: Chemogenetic inhibition of CeA-SST neurons does not affect the paw withdrawal response in the naïve mice. In contrast, the authors themselves showed in their recent paper that optogenetic inhibition of CeA-SST neurons increased paw withdrawal response (Chen et al., 2022, Pain). Please reconcile these two different results in the same lab.</p></disp-quote><p>The reviewer pointed out a key issue regarding the use of in vivo optogenetic manipulations and interpretation of animal behavior. Indeed, we also performed optogenetic inhibition (5-min illumination) of CeA-SST neurons in the control mice in this study (data not shown in the submitted manuscript). The result showed that the mechanical sensitivity was reduced. It was different from our recent paper (Chen et al., 2022) that optogenetic inhibition (10-min illumination) of CeA-SST neurons increased mechanical sensitivity (that is, increased paw withdrawal response). It seems that different illumination protocols resulted in opposite behaviors. Several factors could confound interpretation of optogenetic experiments. First, illumination protocols and intracranial heating could activate or inactivate temperature-sensitive ion channels and thus bias animal behavior (Owen et al., 2019). Second, long-term optogenetic inhibition is known to cause accumulation of intracellular CI<sup>-</sup>, which could alter the E<sub>GABA</sub> and reverse the GABAergic action (Raimondo et al., 2012). In our study, CeA-SST neurons receive reciprocal inhibition from neighboring CeA neurons. In our recent paper (Chen et al., 2022) and our unpublished data, yellow-light stimulation was applied to the naïve mice to activate the NpHR3.0 for 10 minutes. This could lead to intracellular Cl<sup>-</sup> accumulation after termination of light pulse and cause an increase in excitability or rebound action potential generation in the CeA-SST neurons. Because of several experimental parameters of optogenetic manipulations can result in different behaviors, we decided to employ chemogenetic manipulations in this study.</p><p>References:</p><p>Owen SF, Liu MH, Kreitzer AC. (2019) Thermal constraints on in vivo optogenetic manipulations. Nat Neurosci <italic>22</italic>, 1061-1065. Doi: 10.1038/s41593-019-0422-3.</p><p>Raimondo JV, Kay L, Ellender TJ, Akerman CJ. (2012). Optogenetic silencing strategies differ in their effects on inhibitory synaptic transmission. Nat Neurosci <italic>15</italic>, 1102-1104. Doi:10.1038/nn.3143.</p><p>Chen WH, Lien CC, Chen CC. (2022). Neuronal basis for pain-like and anxiety-like behaviors in the central nucleus of the amygdala. Pain <italic>163,</italic> e463-e475. Doi:10.1097/j.pain.0000000000002389.</p><disp-quote content-type="editor-comment"><p>5, There is no data on a2d VGCC subunit expression in parabrachial or CeA in the chronic MP model in this manuscript. Given so much emphasis on PGB results, this information is crucial and is missing here.</p></disp-quote><p>Thanks for the reviewer’s comments. Cole et al., 2005 had described the anatomical distribution of α2δ VGCC subunit expression across the whole rat brain. It revealed that the α2δ VGCC subunit is expressed in the parabrachial nucleus and CeA. In the revised submission, we also provide published data by Allen Brain Institute (α2δ1: http://mouse.brain-map.org/experiment/show?id=72119649; α2δ2:http://mouse.brain-map.org/experiment/show?id=72119650), which show α2δ1 and α2δ2 VGCC subunit expression in the parabrachial in our supplement file (Figure 1 —figure supplement 2).</p><p>References:</p><p>Cole RL, Lechner SM, Williams ME, Prodanovich P, Bleicher L, Varney MA, Gu G. (2005). Differential distribution of voltage-gated calcium channel α-2 δ (alpha2delta) subunit mRNA-containing cells in the rat central nervous system and the dorsal root ganglia. J Comp Neurol <italic>491</italic>, 246-269. Doi:10.1002/cne.20693.</p><disp-quote content-type="editor-comment"><p>6, The authors performed the in vivo calcium imaging of CeA-SST neurons in response to PGB. It would be more informative to know how CeA-SST neurons or CeA-PKCd neurons respond to 1st and 2nd acid injection.</p></disp-quote><p>Indeed, it would be interesting to know how CeA-SST neurons or CeA-PKCδ neurons respond to 1<sup>st</sup> and 2<sup>nd</sup> acid injection. However, it is not the focus of this study. We speculate that several induction protocols including acidic saline injection or complete Freund’s adjuvant injection for chronic pain can differentially activate these two CeA neurons subtype. The latency of their activation in response to induction stimuli may be different. We plan to investigate how CeA-SST neurons or CeA-PKCδ neurons activate during induction in different types of chronic pain mouse models in the future.</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Specifically:</p><p>1) The text is often hard to read and should be carefully checked to improve readability. If needed, a professional writer could be helpful.</p></disp-quote><p>To improve the readability of the manuscript, we have submitted the manuscript to the Wiley Editing Services for professional editing.</p><disp-quote content-type="editor-comment"><p>2) All the reviewers acknowledged the additional excel database and your explanations regarding the data in Figure 3 – supplement 2 B-D. These data were submitted to support the electrophysiological results – that SST+ neuron excitability is selectively enhanced in MP mice. (See also comments of Reviewer 3 in their original review)</p><p>However, some improvements are needed:</p><p>a) We think that you pooled the data from &quot;all slices&quot; together at a given AP position relative to Bregma, to generate the plots and calculate SEM. However, we think you should re-calculate the mean at each AP position for each animal first, then average across animals and calculate SEM. In this way, the data would be averaged within an animal and the variance would be calculated between animals in order to assess the robustness of the results;</p></disp-quote><p>In the revised version of the manuscript, we conducted a new set of experiment (n = 5 animals in each group). As the reviewer suggested, we calculated the mean at each AP position for each animal first, then average across animals and calculate SEM (Figure 3 —figure supplement 2B, left). Similar to our previous results, the number of pERK cells was increased in the MP mice as compared to the Ctrl mice (Ctrl, 197.8 ± 16.5, n = 5; MP, 321.0 ± 30.6, n = 5; Mann–Whitney test, U = 1, *<italic>p</italic> = 0.016; Figure 3 —figure supplement 2B, right). Notably, the total number of SST(+)pERK(+) in the CeA was increased in the MP mice (Ctrl, 8.2 ± 1.0, n = 5; MP, 22.0 ± 3.7, n = 5; Mann–Whitney test, U = 1, *<italic>p</italic> = 0.016; Figure 3 —figure supplement 2C, right). In contrast, the total number of SST(-)pERK(+)cells in the CeA was slightly, but not significantly, increased in the MP mice (Ctrl, 189.6 ± 17.0, n = 5; MP, 298.8 ± 30.9, n = 5; Mann–Whitney test, U = 3, n.s., non-significant, <italic>p</italic> = 0.06; Figure 3 —figure supplement 2D, right).</p><disp-quote content-type="editor-comment"><p>b) Explain why the number of slices at a given AP position varies dramatically across animals (some animals have 1 slice, some have 5-9 slices at a given AP-position). Furthermore, how it could be that in some mice the AP position has 5-9 slices, whereas from the method one can calculate that a maximum of 3 slices can be obtained for a given AP position;</p></disp-quote><p>Thanks for pointing out this potential problem. The reason why some animals have 1 slice and some have 5-9 slices at a given AP position is because of the variation in the slice integrity and the slicing angle of each mouse. We agree with the reviewer that the number of slices should be consistent at a given AP position in an animal and should be less variable across animals. To this end, we conducted a new set of experiment and collected 2-5 slices at each AP position per mouse.</p><disp-quote content-type="editor-comment"><p>c)Tthe number of samples for each bregma level and animal should be similar and more control data should be collected and included since currently they show large variability;</p></disp-quote><p>In the revised version, we conducted a new set of experiment (n = 5 animals in each group) to have the same number of animals in each group.</p><disp-quote content-type="editor-comment"><p>d) Statistical analysis should be improved, e.g. a two-factor analysis of variance (with equal replications) would be a good way to analyze these data.</p></disp-quote><p>In the revised version, we conducted a new set of experiment. Both control and MP groups had equal numbers of animals. As the reviewer suggested, we used the two-way ANOVA with the Bonferroni's multiple comparison test to calculate the statistic power in the diary plot of panel B-D. Consistent to our previous results, the total number of pERK cells in the CeA along the AP axis was increased in the MP mice as compared to the Ctrl mice (Ctrl, n = 5; MP, n = 5; two-way ANOVA, F(1,64) = 29.66; <italic>p</italic> &lt;0.0001 ; Figure 3 —figure supplement 2B, left). Similarly, the number of SST(+)pERK cells was increased in the MP mice as compared to the Ctrl mice (Ctrl, n = 5; MP, n = 5; two-way ANOVA, F(1,64) = 34.12; <italic>p</italic> &lt;0.0001 ; Figure 3 —figure supplement 2C, left). Moreover, the numbers of SST(+)pERK(+) neurons at -1.46 and -1.58 AP position in the MP mice were significantly greater than those in the Ctrl mice (AP: -1.46: Ctrl, 1.33 ± 0.52, n = 5; MP, 3.74 ± 1.43, n = 5; two-way ANOVA with Bonferroni's multiple comparison test, F(1,64) = 34.12, *<italic>p</italic> = 0.039; AP: -1.58: Ctrl, 0.68 ± 0.49, n = 5; MP, 3.06 ± 0.61, n = 5; two-way ANOVA with Bonferroni's multiple comparison test, F(1,64) = 34.12, *<italic>p</italic> = 0.047; Figure 3 —figure supplement 2C, left). Likewise, the number of SST(-)pERK(+) cells in the CeA along the AP axis was increased in the MP mice as compared to the Ctrl mice (Ctrl, n = 5; MP, n = 5; two-way ANOVA, F(1,64) = 24.4; <italic>p</italic> &lt;0.0001 ; Figure 3 —figure supplement 2D, left).</p><p>Finally, we took the comment of the reviewer 3 and compared the total number of cells in the CeA, instead of the averaged number across sections. Compared to the Ctrl mice, the total number of pERK cells was increased in the MP mice (Ctrl, 197.8 ± 16.5, n = 5; MP, 321.0 ± 30.6, n = 5; Mann–Whitney test, U = 1, *<italic>p</italic> = 0.016; Figure 3 —figure supplement 2B). Similarly, the total number of SST(+)pERK(+) cells in the CeA was also increased in the MP mice (Ctrl, 8.2 ± 1.0, n = 5; MP, 22.0 ± 3.7, n = 5; Mann–Whitney test, U = 1, *<italic>p</italic> = 0.016; Figure 3 —figure supplement 2C). In contrast, the total number of SST(-)pERK(+) cells was slightly, but not significantly, increased in the MP mice (Ctrl, 189.6 ± 17.0, n = 5; MP, 298.8 ± 30.9, n = 5; Mann–Whitney test, U = 3, n.s., non-significant, <italic>p</italic> = 0.06; Figure 3 —figure supplement 2D).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>I think that the Authors have done a good job in revising the manuscript according to my suggestions.</p></disp-quote><p>Thanks for the positive comment of the reviewer 1.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The work by Lin and coworkers addresses the important and of broad interest process that underlies the progression of transient pain into persistent pain. This study used a number of sophisticated techniques to dissect the synaptic and cellular mechanisms that occur in the mouse central amygdala (CeA) during the development of chronic muscle pain. In particular, the study reveals shifts in opposite directions of the activity of somatostatin-expressing (SST+) and PKCδ+ neurons. Pharmacological and chemogenetic manipulation of these neurons prevented the chronification of pain and of the comorbid affective behaviors, although with important differences between these two neuronal classes.</p><p>In their revised manuscript, the authors have made a number of significant changes by which they could adequately address my main concerns. In particular, the additional experimental data aimed at increasing the sample size of the behavioural experiments has appreciably improved the manuscript.</p><p>While the text has improved, it still contains several syntax and grammar errors that need to be corrected.</p></disp-quote><p>Thanks to the positive comment of the reviewer 2. We have rechecked the manuscript and corrected the syntax and grammar errors. Furthermore, we have submitted the manuscript to the Wiley Editing Services for improvement of readability.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>I do have some questions for Figure 3—figure supplement 2</p><p>In D, the number of SST(-)pERK(+) in the Ctrl (-1.82 mm) is above 40, while in B, the number of total pERK(+) in the Ctrl (-1.82mm) is about 30. This is weird. How could total number of pERK<sup>+</sup> cells in B being less than that in D (a subset of neurons)?</p></disp-quote><p>In the previous version, we found that we mistakenly caused a slight shift of the control diary plot in the panel B. Together with the reviewer’s concern about the variability of slices at a given AP position and the different number of animals between the control and MP groups, we discarded the previous data and conducted a new set of experiment (see our response to comments in Essential revisions).</p><disp-quote content-type="editor-comment"><p>Authors concluded in Line 212-213, &quot;increased pERK-positive cells are mostly CeA-SST cells.&quot; From the results shown in C and D, it's difficult to be convinced of this statement: the number of SST(+) pERK(+) cells increased from 1.1 to 3.7, while SST(-) pERK(+) cells increased from 18 to 28, even though statistics appeared to be not significant. I believe that instead of comparing the averaged number across sections, comparing the total number of cells in the CeA makes more sense.</p></disp-quote><p>For the new data, we took the reviewer’s comment and compared the total number of cells in the CeA. Compared to the Ctrl mice, the total number of pERK cells was increased in the MP mice (Ctrl, 197.8 ± 16.5, n = 5; MP, 321.0 ± 30.6, n = 5; Mann–Whitney test, U = 1, *<italic>p</italic> = 0.016; Figure 3 —figure supplement 2B). Similarly, the total number of SST(+)pERK(+) cells in the CeA was also increased in the MP mice (Ctrl, 8.2 ± 1.0, n = 5; MP, 22.0 ± 3.7, n = 5; Mann–Whitney test, U = 1, *<italic>p</italic> = 0.016; Figure 3 —figure supplement 2C). In contrast, the total number of SST(-)pERK(+) cells was slightly, but not significantly, increased in the MP mice (Ctrl, 189.6 ± 17.0, n = 5; MP, 298.8 ± 30.9, n = 5; Mann–Whitney test, U = 3, n.s., non-significant, <italic>p</italic> = 0.06; Figure 3 —figure supplement 2D).</p><disp-quote content-type="editor-comment"><p>The &quot;gray&quot; bars for &quot;control&quot; samples in panel B (total pERK<sup>+</sup>) and in panel D (SST-/pERK<sup>+</sup>) appear identical. Could there be an image duplication here?</p></disp-quote><p>In our old data, the &quot;gray&quot; bars for &quot;control&quot; samples in panel B (total pERK<sup>+</sup>) and in panel D (SST-/pERK<sup>+</sup>) appear similar, but not identical. Consistent with our old result, the diary plots and histograms in the new data indeed showed similar distribution (Figure 3 —figure supplement 2 – source data 1).</p></body></sub-article></article>